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 Cell Treatments for Fluorescence Studies 
U2OS cells were plated on a collagen-coated 96 well plate at approximately 2800 cells 
per well. After an overnight incubation, the cells were exposed to leiodermatolide 
continuously for 24 hours. Five replicate wells were treated with each concentration of 
leiodermatolide and three wells were treated with the negative and positive controls. 
DMSO was used as the solvent for leiodermatolide and thus 1% DMSO in culture media 
was the negative control, the positive controls were Mitomycin-C as a clastogenic control 
for micronucleus induction and Nocodazole as the positive control for induction of 
tubulin damage, centrosome amplification and micronuclei.  
 Cell Harvest and Staining 
At the end of the 24-hour exposure, leiodermatolide was removed and cells were fixed 
directly in the 96 well plates with 100% ice cold methanol for 10 minutes. Cells were 
washed twice with Phosphate Buffered Saline (PBS) solution and then placed in blocking 
buffer containing 5% normal goat serum for 60 minutes at room temperature. A 1:1000 
primary probe solution containing rabbit anti-pericentrin antibody and monoclonal anti-
alpha tubulin antibody in mouse was prepared in antibody dilution solution. After 
removing the blocking buffer, cells were placed in primary probe solution overnight at 
4°C. The next day, cells were washed twice with PBS and a secondary probe solution 
containing a 1:1000 goat anti-rabbit Alexa 488 (stain for centrosome), a 1:1000 goat anti-
mouse Alexa 647 (stain for tubulin) and 1:1000 DAPI ((Biotium; stain for DNA) in PBS 
was applied for 30 minutes at room temperature. Following three washes with PBS, cells 
were covered with 200 microL PBS and the plate sealed in preparation for image 
analysis. 
 Cell Analysis 
The cells were analyzed using the Cell Cycle Analysis version 4 bioapplication on the 
ArrayScan VTi HCS Reader (ThermoFisher) with 20X objective. The algorithm uses the 
DNA-binding dye DAPI to classify cells based on intensity and size parameters. Using 
the distribution of DNA content, gates are set to determine the percent of cells in each 
cell cycle phase (< 2N, 2N, 2–4N, 4N, and > 4N corresponds to SubG1, G0/G1, S, G2/M 
and polyploidy cells, respectively.). A minimum of 1000 nuclei per well were analyzed 
for cell cycle.  
The average number of nuclei per field is calculated by the algorithm and this is 
compared to the negative control as the toxicity endpoint. 
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Centrosome spots are identified via a mask that is created around the nuclei, followed by 
the algorithm using intensity and size parameters to identify spots within the mask. A 
minimum of 1000 nuclei per well are analyzed for centrosome spots. Nuclei containing 
greater than 2 centrosome spots are considered to have amplification and the percent 
amplification for each dose is calculated. For this analysis the cells from replicate wells 
are pooled and bucketed into categories based on the number of centrosomes. 
The cells were analyzed on a ThermoFisher ArrayScan VTi using the Micronucleus 
bioapplication and a 20X objective. The algorithm uses intensity and size parameters to 
identify the nuclear mask for each valid nucleus and micronucleus. Micronuclei are 
distinguished from nuclei based on size and proximity to a main nucleus. A minimum of 
1000 nuclei per well are analyzed for micronuclei. The percent micronucleus induction is 
calculated by dividing the number of micronuclei by the total number of nuclei in the 
well. Statistics are performed using GraphPad Prism software. The treated cultures are 
compared to the negative control using a one way analysis of variance (ANOVA) with a 
Dunnett’s multiple comparison follow up. The positive controls are evaluated with an 
unpaired t test and a two-tailed p value is reported. 






Figure S1: Representative image analysis field used to calculate cell cycle values. Arrow 




 Cytotoxicity Assay 
 N87 (gastric carcinoma), MDA-MB-361-DYT2 (breast carcinoma), HT29 (colon 
carcinoma), HL60 (leukemia), NB4 (leukemia), HEL (leukemia) and Raji (leukemia) 
cells were used to assess the anti-proliferative capacity of the compounds. Cells were 
seeded in 96-well plates at low density, then treated the following day with compound in 
3-fold serial dilutions at 10 concentrations in duplicate. Cells were incubated for 4 days 
in a humidified 37
o
C/5% CO2 incubator. The plates were harvested by incubating with 
CellTiter® 96 AQueous One MTS Solution (Promega, Madison, WI) for 1.5 hour and 
absorbance measured on a Victor plate reader (Perkin-Elmer, Waltham, MA) at 
wavelength 490 nm. GI50 values were calculated using a four-parameter logistic model 
with XLfit (IDBS, Bridgewater, NJ). 
 
Broad Panel Kinase Screen 
Biochemical Kinase Screening Method (International Centre for Kinase Profiling, 
Dundee). At the International Centre for Kinase Profiling (ICKP) a radiometric filter 
binding assay is used to determine inhibitor specificity and potency at an approximate 
Km concentration of ATP. This method is sensitive, accurate and provides a direct 
measure of enzyme activity in the presence of inhibitors. The method utilized for lipid 
kinase screening is the Promega ADP Glo High Throughput Assay Kit. The principle of 
this assay is that it is a measurement of the ADP generated as a function of the enzyme 
reaction. 
Biochemical Kinase Screening Method (Invitrogen, a Life Technology company). 
Invitrogen screening service uses a FRET-based kinase assays to assess inhibitor potency 
at a Km concentration of ATP. The experiments were conducted in Invitrogen Inc. 
(Carlsbad, CA) in their Madison, WI, facility. Most of the kinase panel assays were the 
FRET-based Z´-LYTE® assays that employ a fluorescence-based, coupled-enzyme 
format, taking advantage of the differential sensitivity of phosphorylated and non-
phosphorylated peptides to proteolytic cleavage. Some kinases were tested using the TR-
FRET-based Adapta® assay format that employs the Alexa Fluor® 647 labeled ADP 
tracer and Eu-labeled anti-ADP antibody. The assays of the above two formats were 
normally conducted with ATP concentrations near the KM,app. Another assay format 
used was the TR-FRET-based LanthaScreen® binding assays utilizing an Alexa Fluor® 
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Figure S2: Kinase panel screen at 1 µM compound concentration. Color coding: green 




X-ray diffraction data for both compounds were collected using a Bruker AXS X8 
Proteum diffractometer housed in front of a FR591 rotating anode equipped with graded 
multilayer focusing optics (Cu K,  = 1.54184 Å) employing  and  scans to cover 
reciprocal space up to 67° 2 with 99% completeness. The structures were solved by 
direct methods using SHELXS-97. Atomic positions and displacement parameters were 





















 Scheme S2. Synthesis of analogues 42, 45 and 46. 
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Total Synthesis of Leiodermatolide 
 
General. All reactions were carried out under Ar in flame-dried glassware. The solvents 
were purified by distillation over the drying agents indicated and were transferred under 
Ar: THF, Et2O (Mg/anthracene), CH2Cl2, MeCN (CaH2), hexane, toluene (Na/K), MeOH 
(Mg), DMF (MS 4Å), DMSO (distilled over CaH2, stored over MS 4Å). Microwave-
assisted reactions: All reactions under microwave irradiation were performed at the 
specified temperature in a Biotage
®
 Initiator 2.5 system equipped with a build-in pressure 
sensor and an IR temperature measurement sensor. Flash chromatography: Merck silica 
gel 60 (40–63 µm) or Florisil® (60-100 mesh). NMR: Spectra were recorded on Bruker 
DPX 300, AV 400, AV 500 or AVIII 600 spectrometers in the solvents indicated; 
chemical shifts (δ) are given in ppm relative to TMS, coupling constants (J) in Hz. The 
solvent signals were used as references and the chemical shifts converted to the TMS 
scale (CDCl3: δC 77.16 ppm; residual CHCl3 in CDCl3: δH 7.24 ppm; CD2Cl2: 
δC53.80 ppm; residual CDHCl2: δH5.32 ppm; C6D6: δC128.06 ppm; residual 
C6D5H: δH7.16 ppm, DMSO-d6: δC39.52 ppm, residual CD2HS(O)CD3: δH2.50 
ppm). IR: Spectrum One (Perkin-Elmer) spectrometer, wavenumbers ( ) in cm1. MS 
(EI): Finnigan MAT 8200 (70 eV), ESI-MS: ESQ3000 (Bruker), accurate mass 
determinations: Bruker APEX III FT-MS (7 T magnet) or Mat 95 (Finnigan). Unless 
stated otherwise, all commercially available compounds (Fluka, Lancaster, Aldrich) were 
used as received. 
 
 Synthesis of the Enyne Segment 6 
Diethyl 2-(diiodomethyl)-2-methylmalonate (14). A solution of diethyl methylmalonate 
(13) (9.81 mL, 57.0 mmol) in Et2O (20 mL) was added over 30 min 
to a suspension of NaH (1.65 g, 69.0 mmol) in Et2O (100 mL), 
causing the mixture to reach reflux temperature while vigorous 
evolution of H2 was noticed. Once the addition was complete, the mixture was stirred at 
reflux for 1.5 h before solid CHI3 (22.6 g, 57.0 mmol) was added. Stirring was continued 
at reflux temperature for 12 h before the mixture was cooled to 0 °C and excess NaH was 
carefully quenched with aq. HCl (1 M, 100 mL). After stirring for 20 min, the layers were 
separated and the aqueous layer was extracted with Et2O (3 x 65 mL). The combined 
organic layers were washed with brine (80 mL), dried over Na2SO4 and concentrated in 
vacuo to yield the title compound as a light brown viscous liquid (24.9 g, 99%), which 
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was used in the next step without further purification. 
1
H NMR (400 MHz, CDCl3): δ = 
5.73 (br s, 1H), 4.18 (dq, 4H, J = 7.1 Hz, 1.4 Hz), 1.75 (s, 3H), 1.25 (t, 6H, J = 7.1 Hz); 
13
C NMR (100 MHz, CDCl3): δ = 166.2, 62.8, 62.3, 20.5, 14.1, ‒25.8; IR (film):   = 
1731, 1447, 1380, 1366, 1261, 1207, 1162, 1093, 1074, 1015, 859 cm
-1
; MS (EI) m/z 
(%): 440 (12), 313 (9), 241 (22), 213 (27), 195 (17), 167 (12), 113 (7), 85 (12), 41 (16), 
39 (23), 29 (100), 27 (15); HRMS (ESI): m/z: calcd. for C9H14O2I2Na [M
+
+Na]: 
462.88737, found 462.88705. The analytical and spectroscopic data are in agreement 
with those reported in the literature.
2
 When applied to 20.5 mL (120 mmol) of compound 
13, this reaction yielded 52.2 g (>98%) of compound 4. 
(E)-3-Iodo-2-methylacrylic acid (15). KOH (15.9 g, 283 mmol) and H2O (60 mL) were 
added to a solution of crude malonate 14 (24.8 g, 56.3 mmol) in EtOH 
(180 mL), and the resulting red solution was stirred at reflux temperature 
for 4 h. After cooling and evaporation of all volatile materials, the residue 
was dissolved in aq. K2CO3 (10% w/w, 150 mL), which was then carefully 
acidified with conc. HCl at 0 °C. Extraction with CH2Cl2 (8 x 50 mL) was followed by 
drying of the combined organic layers over Na2SO4 and concentration in vacuo. The 
residue was purified by flash chromatography (silica, hexanes/EtOAc, 9:1 + 0.5% HOAc) 
to yield the title compound as a light yellow solid (8.58 g, 72%). 
1
H NMR (400 MHz, 
CDCl3): δ = 12.28 (br s, 1H), 8.00 (q, 1H, J = 1.2 Hz), 2.03 (d, 3H, J = 1.2 Hz); 
13
C 
NMR (100 MHz, CDCl3): δ = 169.5, 139.2, 102.3, 20.0; IR (film):  = 3079, 2966, 2596, 
1682, 1593, 1409, 1379, 1296, 1235, 1108, 991, 915, 838, 727, 685 cm
-1
; MS (EI) m/z 
(%): 212 (56), 167 (6), 127 (6), 85 (75), 57 (12), 45 (14), 43 (11), 41 (28), 40 (16), 39 
(100), 38 (18), 37 (9), 29 (18); HRMS (EI): m/z: calcd. for C4H5O2I [M]: 211.93343, 
found 211.93359. The analytical and spectroscopic data are in agreement with those 
reported in the literature.
3
 When applied to 123 g (280 mmol) of compound 14 this 
reaction yielded 54.0 g (91%) of compound 15. 
 Alternative synthesis of (E)-3-iodo-2-methylprop-2-en-1-ol. BH3•THF (1 M in THF, 
60.0 mL, 60 mmol) was added over 2 h at ‒15 °C to a solution of acid 15 
(10.6 g, 50.0 mmol) in THF (50 mL). The reaction mixture was allowed to 
reach room temperature and was stirred at this temperature for 2 h, when a 
second aliquot of BH3•THF (1 M in THF, 15.0 mL, 15 mmol) was introduced. 
After additional 2 h, the mixture was carefully quenched by the slow addition of aq. 
K2CO3 (10% w/w, 50 mL) at 0 °C. After stirring for 10 min, the mixture was diluted with 
H2O (50 mL) and MTBE (50 mL), and the aqueous layer was extracted with MTBE (2 x 
100 mL). The combined organic layers were washed with brine, dried over Na2SO4 and 
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concentrated in vacuo. The residue was purified by flash chromatography (silica, 
pentane/Et2O, 3:1) to yield the title compound as a light yellow liquid (7.40 g, >60% 
pure). An aliquot of this mixture was used in the next step without further purification. 
1
H 
NMR (400 MHz, CDCl3): δ = 6.25 (m, 1H), 4.09 (d, 2H, J = 5.4 Hz), 1.85 – 1.81 (m, 
4H); 
13
C NMR (100 MHz, CDCl3): δ = 147.4, 77.5, 67.3, 21.5; IR (film):  = 3295, 2912, 
2851, 1620, 1433, 1376, 1274, 1252, 1145, 1066, 1008, 942, 829, 771, 665 cm
-1
; MS (EI) 
m/z (%): 198 (75), 183 (5), 127 (9), 71 (100), 53 (28), 43 (59), 31 (57), 39 (61), 38 (12), 
31(34), 29(14), 27(26); HRMS (EI): m/z: calcd. for C4H7IO [M]: 197.95416, found 
197.95410. The analytical and spectroscopic data are in agreement with those reported in 
the literature.
2 
 Alternative synthesis of allylic aldehyde 16. [Cu(MeCN)4] (236 mg, 750 μmol), 2,2’-
bipyridine (117 mg, 750 μmol), TEMPO (117 mg, 750 μmol), and 1-
methylimidazole (120 μL, 1.5 mmol) were successively added to a round-
bottom flask purged with O2 and containing a solution of (E)-3-iodo-2-
methylprop-2-en-1-ol (2.97 g, 15.0 mmol) in MeCN (40 mL), inducing a 
color change from light yellow to dark red/brown. The reaction mixture was vigorously 
stirred at room temperature for 1 h under O2 atmosphere (balloon). Completion of the 
reaction occurred with a color change from dark red/brown to green/blue. The mixture 
was diluted with H2O (300 mL) and pentanes (300 mL), the aqueous layer was extracted 
with pentanes (2 x 100 mL). The combined organic layers were dried over Na2SO4, 
carefully concentrated in vacuo (0 °C, 200 mbar) to yield the title compound as an orange 
liquid (2.14 g, 55% over two steps). Due to the unstable nature of this compound, it was 
dissolved in CH2Cl2 containing 4Å MS and was immediately used in the next step. 
1
H 
NMR (300 MHz, CDCl3): δ = 9.52 (s, 1H), 7.8 (q, 1H, J = 1.2 Hz), 1.92 (d, 3H, J = 
1.2 Hz) 
13
C NMR (75 MHz, CDCl3): δ = 189.5, 151.0, 109.6, 16.6; IR (film):  = 2921, 
2842, 1691, 1591, 1294, 1099, 1027, 1015, 798, 679 cm
-1
; MS (EI) m/z (%): 196 (99), 
167 (14), 127 (8), 69 (86), 41 (59), 30 (11), 39 (100), 38 (13), 29 (8); HRMS (EI): m/z: 
calcd. for C4H5IO [M]: 195.93852, found 195.93837.  
(2R,3S,E)-((1R,2S)-2-(N-Benzyl-2,4,6-trimethylphenylsulfonamido)-1-phenylpropyl) 
3-hydroxy-5-iodo-2,4-dimethylpent-4-enoate (17). NEt3 




(2.61 g, 5.43 mmol) were dissolved in CH2Cl2 (45 mL) and the 
solution cooled to ‒78 °C. A solution of dicyclohexyboryl triflate 
(2.13 g, 6.52 mmol) in pentane (12 mL) was then added over 12 min to give a yellow 
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suspension, which was kept at this temperature for 5 h. A solution of freshly prepared 
aldehyde 6 (2.45 g, 12.5 mmol) in CH2Cl2 (10 mL) was then added and stirring continued 
for 1.5 h before the cooling bath was removed and the mixture allowed to reach room 
temperature. After 3 h, the reaction was quenched with aq. pH 7 buffer (30 mL) and 
treated with MeOH (100 mL) and aq. H2O2 (30% w/w, 15 mL) overnight. The mixture 
was concentrated in vacuo, the residue dissolved in CH2Cl2 (150 mL) and the organic 
layer washed with H2O (60 mL). The aqueous layer was extracted with CH2Cl2 
(3 x 50 mL), the combined organic layers were dried over Na2SO4 and concentrated in 
vacuo. 
1
H NMR analysis of the crude product showed a diastereomeric ratio of 13:1. The 
residue was purified by flash chromatography to yield the title compound as a white solid 
(2.79 g, 76%, single isomer). D20][  = +45.0 (c = 0.95, CH2Cl2); 
1
H NMR (400 MHz, 
CDCl3): δ = 7.33 – 7.13 (m, 8H), 6.87 (s, 2H), 6.86- 6.82 (m, 2H), 6.28 (s, 1H), 5.83 (d, 
1H, J = 4.0 Hz), 4.73 (d, 1H, J = 16.7 Hz), 4.54 (d, 1H, J = 16.7 Hz), 4.23 (dd, 1H, J = 
8.9, 3.8 Hz), 4.09 (dq, 1H, J = 4.0, 7.0 Hz), 2.73 (d, 1H, J = 4.1 Hz, 1H), 2.64 – 2.52 (m, 
1H), 2.48 (s, 6H), 2.26 (s, 3H), 1.80 (d, 3H, J = 1.1 Hz), 1.15 (d, 3H, J = 7.0 Hz), 0.94 
(d, 3H, J = 7.23 Hz); 
13
C NMR (100 MHz, CDCl3): δ = 174.1, 147.0, 142.7, 140.4, 
138.7, 138.2, 133.5, 132.2, 128.6, 128.4, 128.1, 127.7, 127.3, 126.0, 81.3, 78.7, 78.6, 
56.9, 48.4, 43.4, 23.1, 21.0, 18.9, 14.2, 13.5; IR (film):  = 3496, 1741, 1604, 1496, 1455, 
1379, 1317, 1151, 1117, 1031, 1011, 929, 858, 752, 730, 698, 659 cm
-1
; MS (EI) m/z 
(%): 406 (1), 317 (20), 316 (100), 183 (5), 119 (17), 91 (60), 57 (3), 41 (3); HRMS (ESI): 
m/z: calcd. for C32H38NO5ISNa [M
+
+Na]: 698.14076, found 698.14108. The analytical 




(17a). 2,6-Lutidine (0.863 mL, 7.43 mmol) was added via syringe 
to a stirred solution of alcohol 17 (2.51 g, 3.71 mmol) in CH2Cl2 
(20 mL). The mixture was cooled to 0 °C before TBSOTf (1.28 mL, 
5.57 mmol) was slowly added. After stirring for 2 h at 0 °C, the 
reaction was quenched with sat. aq. NH4Cl, the aqueous layer was extracted with CH2Cl2 
(3 x 20 mL), the combined organic layers were washed with brine, dried over Na2SO4 
and concentrated in vacuo to yield the title compound as a white solid, which was used in 
the next step without further purification (2.89 g, 95%). An analytically pure sample was 
obtained by flash chromatography (hexanes/EtOAc, 9:1). D20][  = +36.3 (c = 0.85, 
CHCl3); 
1
H NMR (400 MHz, CDCl3): δ = 7.38 (d, 2H, J = 7.3 Hz), 7.30 – 7.22 (m, 3H), 
7.19 – 7.13 (m, 1H), 7.07 (t, 2H, J = 7.5 Hz), 6.85 (s, 2H), 6.7 (d, 2H, J = 7.3 Hz), 6.18 
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(s, 1H), 5.67 (d, 1H, J = 6.0 Hz), 4.85 (d, 1H, J = 16.1 Hz), 4.37 (d, 1H, J = 16.1 Hz), 
4,29 (d, 1H, J = 9.3 Hz), 4.04 (dq, 1H, J = 6.6, 6.6 Hz), 2.61 (dq, 1H, J = 9.1, 7.3 Hz), 
2.39 (s, 6H), 2.29 (s, 3H), 1.73 (d, 3H, J = 0.8 Hz), 1.16 (d, 3H, J = 6.9 Hz), 0.80 (s, 9H), 
0.74 (d, 3H, J = 7.2 Hz), ‒0.03 (s, 3H), ‒0.05 (s, 3H); 13C NMR (100 MHz, CDCl3): δ = 
173.0, 147.7, 142.5, 140.6, 138.6, 138.1, 133.1, 132.3, 128.6, 128.5, 128.4, 128.0, 127.5, 
126.6, 80.8, 79.4, 77.9, 56.7, 48.3, 44.9, 25.9, 23.0, 21.0, 18.8, 18.3, 15.1, 14.0, ‒4.9, 
‒5.0; IR (film):   = 2956, 2935, 2857, 1743, 1605, 1455, 1379, 1325, 1254, 1154, 1072, 
1030, 1011, 929, 857, 836, 777, 729, 698, 659 cm
-1
; MS (EI) m/z (%): 406 (23), 317 (21), 
316 (100), 183 (6), 132 (7), 119 (20), 91 (62), 73 (11); HRMS (ESI): m/z: calcd. for 
C38H52NO5ISSiNa [M
+
+Na]: 812.22724, found 812.22802. 
(2S,3S,E)-3-(tert-Butyldimethylsilyloxy)-5-iodo-2,4-dimethylpent-4-en-1-ol (17b). 
DIBAl-H (1 M in toluene, 9.38 mL, 9.38 mmol) was added over a period of 
12 min to a solution of silyl ether 17a (2.89 g, 95% pure, 3.48 mmol) in 
toluene (25 mL) at ‒78 °C. After stirring 2 h at this temperature, excess of 
DIBAl-H was carefully quenched with MeOH (2 mL). The mixture was 
diluted with MTBE (20 mL) and sat. aq. Rochelle salt (30 mL). The resulting mixture 
was stirred overnight at room temperature before the aqueous layer was extracted with 
MTBE (3 x 30 mL). The combined organic layers were washed with brine (25 mL), dried 
over Na2SO4 and concentrated in vacuo. The residue was purified by flash 
chromatography (silica, hexanes/EtOAc, 9:1) to yield the title compound as a colorless 
viscous liquid (1.07 g, 83% over two steps). D20][  = ‒32.3 (c = 1.05, CHCl3); 
1
H NMR 
(400 MHz, CDCl3): δ = 6.18 (s, 1H), 4.00 (d, 1H, J = 8.0 Hz), 3.61 (dd, 1H, J = 4.5, 
0.7 Hz), 3.60 (d, 1H, J = 4.8 Hz), 2.44 (t, 1H, J = 5.68 Hz), 1.88 – 1.78 (m, 1H), 1.76 (d, 
3H, J = 1.0 Hz), 0.88 (s, 9H), 0.78 (d, 3H, J = 7.0 Hz), 0.06 (s, 3H), ‒0.02 (s, 3H); 13C 
NMR (100 MHz, CDCl3): δ = 149.0, 83.0, 79.4, 66.3, 38.8, 25.9, 19.6, 18.2, 14.1, ‒4.6, 
‒5.2; IR (film):  = 339, 2956, 2928, 2884, 2857, 1615, 1471, 1462, 1376, 1361, 1252, 
1140, 1064, 1037, 1004, 982, 938, 834, 774, 672 cm
-1
; MS (EI) m/z (%): 313 (46), 311 
(23), 271 (18), 185 (52), 171 (16), 115 (6), 111 (9), 75 (100), 73 (44), 53 (6), 45 (5), 43 
(5), 41 (6); HRMS (ESI): m/z: calcd. for C13H27O2ISiNa [M
+
+Na]: 393.07172, found 
393.07146. 
(2R,3S,E)-3-(tert-Butyldimethylsilyloxy)-5-iodo-2,4-dimethylpent-4-enal (18). A 
solution of alcohol 17b (600 mg, 1.62 mmol) in CH2Cl2 (6 mL) was added 
to a suspension of Dess-Martin periodinane (756 mg, 1.78 mmol) in 
CH2Cl2 (10 mL) at 0 °C. After stirring for 15 min, the mixture was 
allowed to warm to room temperature and stirring continued for 2 h. The 
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reaction was quenched with sat. aq. Na2S2O3/Na2CO3 (1:1, 10 mL), the aqueous layer 
extracted with CH2Cl2 (3 x 10 mL), and the combined organic layers were dried over 
Na2SO4 and concentrated in vacuo. The residue was suspended in hexane/EtOAc (9:1) 
and the resulting suspension filtered through a short pad of SiO2. The filtrate was then 
concentrated in vacuo to yield the rather unstable aldehyde 18, which was immediately 
used in the next step (586 mg, 98%). 
1
H NMR (500 MHz, CDCl3): δ = 9.73 (d, 1H, J = 
2.7 Hz), 6.28 (s, 1H), 4.27 (d, 1H, J = 8.4 Hz), 2.59 (dqd, 1H, J = 8.4, 7.1, 2.5 Hz), 1.79 
(d, 3H, J = 1.0 Hz), 0.88 (d, 3H, J = 7.1 Hz), 0.85 (s, 9H), 0.03 (s, 3H), ‒0.03 (s, 3H); 
13
C NMR (125 MHz, CDCl3): δ = 203.9, 147.8, 80.3, 79.2, 50.2, 25.7, 19.1, 18.2, 11.0, 
‒4.7, ‒5.2. 
tert-Butyl-((1E,3S,4S,5Z)-1-iodo-2,4-dimethylnona-1,5-dien-7-yn-3-yloxy)dimethylsi-
lane (18a). A precooled (‒78 °C) solution of KHMDS (0.729 g, 
3.66 mmol) in THF (6 mL) was added to a solution of sulfone 20 
(1.00 g, 3.98 mmol) in THF (6 mL) at –55 °C, inducing a color 
change to dark-red. After stirring for 30 min at this temperature, a 
precooled (‒78 °C) solution of aldehyde 9 (586 mg, 1.59 mmol) in THF (3 mL) was 
added dropwise via canula and the resulting mixture stirred at ‒55 °C for 13 h before 
being poured into brine (15 mL) and warmed to room temperature. Then, MTBE (20 mL) 
and H2O (5 mL) were added, the aqueous layer was extracted with MTBE (2 x 20 mL), 
and the combined organic layers were dried over Na2SO4 and concentrated in vacuo. The 
residue was purified by flash chromatography to yield the title compound as a colorless 
viscous liquid (364 mg, 56%). D20][  = +100.1 (c = 1.0, CHCl3); 
1
H NMR (400 MHz, 
CDCl3): δ = 6.09 (m, 1H), 5.61 (dd, 1H, J = 10.3, 10.0 Hz), 5.39 (dq, 1H, J = 10.8, 
2.3 Hz), 3.98 (d, 1H, J = 5.4 Hz), 2.92 (ddq, 1H, J = 9.3, 6.5, 6.4 Hz), 1.94 (d, 3H, J = 
2.4 Hz), 1.76 (d, 3H, J = 0.9 Hz), 0.91 (d, 3H, J = 6.9 Hz), 0.86 (s, 9H), 0.01 (s, 3H), 
‒0.06 (s, 3H); 13C NMR (100 MHz, CDCl3): δ = 149.3, 143.9, 110.0, 89.5, 81.0, 78.1, 
76.8, 39.6, 25.9, 20.8, 18.3, 17.2, 4.6, ‒4.7, ‒5.0; IR (film):   = 2956, 2928, 2885, 2856, 
2332, 2330, 2324, 1615, 1471, 1462, 1361, 1252, 1081, 1019, 1005, 938, 862, 833, 773, 
749, 673 cm
-1
; MS (EI) m/z (%): 347 (6), 312 (16), 311 (100), 146 (7), 127 (8), 115 (12), 
91 (6), 75 (13), 73 (70), 59 (9), 53 (7); HRMS (ESI): m/z: calcd. for C17H29OISiNa 
[M
+
+Na]: 427.09246, found 427.09258. 
(1E,3S,4S,5Z)-1-Iodo-2,4-dimethylnona-1,5-dien-7-yn-3-ol (6). TBAF (1 M in THF, 
1.42 mL, 1.42 mmol) was added to a solution of silyl ether 18a 
(230 mg, 568 µmol) in THF (5 mL) at 0 °C and the mixture was 
stirred at this temperature for 3.5 h before it was quenched with H2O 
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(5 mL), sat. aq. NH4Cl (2 mL) and diluted with MTBE (10 mL). The aqueous layer was 
extracted with MTBE (3 x 10 mL), and the combined organic layers were dried over 
Na2SO4 and concentrated in vacuo. The residue was purified by flash chromatography 
(hexanes/EtOAc, 9:1) to yield alcohol 6 as a colorless viscous liquid (163 mg, 99%). 
D
20][  = +24.0 (c = 0.50, CHCl3); 
1
H NMR (500 MHz, CDCl3): δ = 6.24 (s, 1H), 5.64 (dd, 
1H, J = 10.3 Hz, 10.1 Hz), 5.55 (dq, 1H, J = 10.7 Hz, 2.1 Hz), 3.91 (dd, 1H, J = 8.0 Hz, 
3.1 Hz), 2.97 (dqd, 1H, J = 9.2, 7.2, 7.1 Hz), 1.97 (d, 3H, J = 2.2 Hz), 1.88 (d, 1H, J = 
3.3 Hz), 1.83 (d, 3H, J = 0.8 Hz), 0.90 (3H, d, J = 6.9 Hz); 
13
C NMR (125 MHz, CDCl3): 
δ = 148.3, 143.0, 112.0, 91.0, 80.8, 79.8, 76.2, 38.9, 19.6, 17.0, 4.6; IR (film):  = 3535, 
3419, 2962, 2916, 2873, 2853, 1615, 1454, 1399, 1377, 1271, 1143, 1117, 1072, 1005, 
933, 753, 671 cm
-1
; MS (EI) m/z (%): 290 (1), 197 (59), 163 (10), 95 (9), 94, (100), 93 
(16), 91(26)79 (89), 77 (40), 60 (5), 65 (9), 53 (10), 51 (7), 43 (12), 4 1 (6), 39 (25), 29 
(5); HRMS (EI): m/z: calcd. for C11H15OI [M]: 290.01676, found 290.01657. 
When applied to 405 mg (1.00 mmol) of silyl ether 18a, this reaction yielded 287 mg 
(99%) of 6. 
 
 Synthesis of the Acid Segment 5 
(S)-4-Benzyl-3-((2S,3R)-3-hydroxy-2-methylpentanoyl)oxazolidin-2-one (23a). 
Bu2BOTf (1 M in CH2Cl2, 49 mL, 49.0 mmol) was slowly added to a 
solution of oxazolidinone 23 (9.70 g, 41.6 mmol) in CH2Cl2 (92 mL) 
at 0 °C. Et3N (7.6 mL, 55.0 mmol) was then added at such a rate as to 
keep the internal temperature below 2 °C. Once the addition was 
complete, the mixture was cooled to ‒78 °C before freshly distilled 
propionaldehyde (4.4 mL, 46.4 mmol) was introduced. The mixture was stirred for 30 
min at –78 °C before the CO2/acetone bath was replaced by an ice bath. Stirring was 
continued for 1 h and the reaction quenched with aq. phosphate buffer (46 mL, pH 7) and 
MeOH (138 mL) at such a rate as to keep the internal temperature below ‒6 °C. Then, a 
1:2 mixture of MeOH and aq. H2O2 (30% w/w, 138 mL) was carefully added such that 
the internal temperature never rose above 10 °C. The mixture was stirred for 1 h once the 
addition was complete. After concentration on a rotary evaporator (bath-temperature ca. 
30 °C), Et2O (50 mL) was added to the slurry and the aqueous layer extracted with Et2O 
(3 x 50 mL). The combined organic layers were washed with sat. aq. NaHCO3 (12 mL) 
and brine (12 mL) before being dried over MgSO4. Evaporation of the solvent and flash 
chromatography (silica, hexanes/EtOAc, 3:1) of the residue, followed by recrystallization 
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of the product from Et2O/hexanes yielded the title compound as a white solid (11.71 g, 
97%). D20][  = +20.8 (c = 1.38, CHCl3), 
1
H NMR (300 MHz, CDCl3): δ = 7.36 – 7.25 (m, 
3H), 7.22 – 7.16 (m, 2H), 4.68 (ddq, 1H, J = 13.7, 6.9, 3.4 Hz), 4.27 – 4.12 (m, 2H), 3.89 
– 3.80 (m, 1H), 3.80 – 3.70 (m, 1H), 3.24 (dd, 1H, J = 13.4, 3.3 Hz), 2.76 (dd, 1H, J = 
13.4, 9.5 Hz), 1.88 (br s, 1H), 1.66 – 1.32 (m, 2H), 1.23 (d, 3H, J = 7.0 Hz), 0.96 (t, 3H, J 
= 7.4 Hz); 
13
C NMR (75 MHz, CDCl3): δ = 177.8, 153.2, 135.2, 129.6, 129.2, 127.6, 
73.2, 66.4, 55.3, 41.9, 38.0, 26.9, 10.6, 10.4; IR (film):  = 3466, 2969, 1778, 1696, 1455, 
1385, 1210, 1113, 1030, 969, 762, 749, 702 cm
-1
; MS (EI) m/z (%): 292 (7), 291 (30), 
273 (9), 244 (46), 233 (30), 178 (42), 158 (100), 142 (12), 134 (63), 133 (20), 117 (38), 
116 (23), 115 (49), 97 (26), 91 (56), 86 (80), 77 (7), 69 (34), 57 (45), 42 (15); HRMS 
(ESI): m/z: calcd. for C16H21NO4Na [M
+
+Na]: 314.13628, found 314.13637. The 
analytical and spectroscopic data are in agreement with those reported in the literature.
5
 
When applied to 15.8 g (67.6 mmol) of 23 this reaction yielded 19.2 g (98%) of the aldol 
product 23a. 
(S)-1-((S)-4-Benzyl-2-oxo-oxazolidin-3-yl)-2-methylpentane-1,3-dione (24). The aldol 
product 23a (5.70 g, 19.6 mmol) was dissolved in CH2Cl2 (92 mL) 
and DMSO (92 mL) and the solution cooled to ‒15 °C. Et3N (8.20 ml, 
58.8 mmol) was introduced followed by a dropwise addition of a 
solution of SO3•pyridine (9.40 g, 58.8 mmol) in DMSO (92 mL) and 
the reaction mixture was stirred for 3 h. Then, Et2O (400 mL) was added and the organic 
layer was washed with aq. KHSO4 (1 M, 400 mL), sat. aq. NaHCO3 (400 mL), brine 
(400 mL). Then, the organic layer was dried over MgSO4 and concentrated in vacuo. The 
residue was purified by flash chromatography (silica, hexanes/EtOAc, 6:1  3:1) to yield 
product 24 as a white solid (4.96 g, 88%). Mp = 71-72 °C (hexanes); D20][  = +137.4 (c = 
0.91, CHCl3); 
1
H NMR (300 MHz, CDCl3): δ = 7.39 – 7.29 (m, 3H), 7.27 – 7.18 (m, 2H), 
4.82 – 4.70 (m, 1H), 4.62 (q, 1H, J = 7.3 Hz), 4.31 – 4.09 (m, 2H), 3.33 (dd, 1H, J = 
13.3, 3.3 Hz), 2.85 – 2.57 (m, 3H), 1.46 (d, 3H, J = 7.3 Hz), 1.09 (t, 3H, J = 7.3 Hz); 13C 
NMR (100 MHz, CDCl3): δ = 208.4, 170.5, 154.0, 135.3, 129.6, 129.2, 127.5, 66.7, 55.5, 
52.9, 38.2, 34.2, 13.1, 7.7; IR (film):   = 2985, 1760, 1718, 1702, 1455, 1390, 1360, 
1250, 1213, 1125, 1082, 1082, 1051, 1010, 974, 763, 748, 703 cm
–1
; MS (EI) m/z (%): 
289 (15) [M
+
], 260 (15), 233 (15), 178 (10), 142 (25), 117 (40), 91 (25), 65 (5), 57 (100), 
42 (5); HRMS (ESI): m/z: calcd. for C16H19NO4Na [M
+
 + Na]: 312.12062, found 






When applied to 9.50 g (32.6 mmol) of the aldol product 23a obtained in the previous 
step this reaction yielded 7.22 g (75%) of compound 24. 
Alternative synthesis of but-2-ynal (25). TBACl (6.67 g, 24.0 mmol), TEMPO (3.75 g, 
24.0 mmol) and NCS (51.3 g, 384 mmol, in three portions) were 
successively added to a solution of but-2-ynol (18.0 mL, 240 mmol) in 
CH2Cl2 (350 mL) and aq. pH 8.6 buffer (14.7 g of NaHCO3 and 2.42 g of 
K2CO3 in 350 mL of H2O), inducing a slight exothermic reaction. In order to quench the 
stoichiometric amount of HCl formed during the reaction, the flask was connected to a 
wash-flask filled with 1 M aq. NaOH solution. The resulting biphasic light orange 
mixture was then vigorously stirred at room temperature for 7 h. The aqueous layer was 
extracted with CH2Cl2 (100 mL), the combined organic layers were washed with brine, 
dried over Na2SO4 and directly distilled under reduced pressure at room temperature to 
yield but-2-ynal (25) as a light yellow liquid, which must be stored at low temperature 
(9.44 g, 45%). 
1
H NMR (300 MHz, CDCl3):  = 9.13 (dd, J = 1.8, 0.9 Hz, 1H), 2.05 (d, J 
= 1.0 Hz, 3H). The analytical and spectroscopic data are in agreement with those 
reported in the literature.
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Propargylic alcohol (26). Sn(OTf)2 used in the second syn-aldol reaction was washed 
with Et2O (3 x 6 mL) and dried overnight at 100 °C under 
reduced pressure prior to use. Et3N (324 µL, 2.32 mmol) was 
added dropwise via syringe to a solution of freshly purified 
Sn(OTf)2 (969 mg, 2.32 mmol) in CH2Cl2 (10 mL). After 
cooling to ‒30 °C, a solution of ketone 13 (640 mg, 
2.22 mmol) in CH2Cl2 (3.0 mL) was added via syringe over 5 min and the mixture stirred 
for 1 h at this temperature before it was cooled to ‒78 °C and a solution of but-2-ynal in 
CH2Cl2 (10 M, 1.11 mL, 11.1 mmol) was added dropwise via syringe. After additional 1 
h, the mixture was diluted with CH2Cl2 (30 mL) and added to vigorously stirred aq. 
NaHSO4 (1 M, 50 mL) at 0 °C. This slurry was stirred for 30 min before the aqueous 
layer was extracted with CH2Cl2 (2 x 40 mL). The combined organic layers were washed 
with sat. aq. NaHCO3 (50 mL), dried over Na2SO4 and concentrated in vacuo. The 
residue was purified by flash chromatography (silica, hexanes/EtOAc, 4:1  2:1) to yield 
the the desired isomer as a white solid (1.32 g, 83%). 
1
H NMR analysis of the crude 
product before flash chromatography indicated a diastereomeric ratio of 9.0:1 in favor of 
compound 26. D20][  = +101.1 (c = 0.55, CHCl3); 
1
H NMR (400 MHz, CDCl3): δ = 7.35 
– 7.25 (m, 3H), 7.23 – 7.14 (m, 2H), 4.90 (q, 1H, J = 7.3 Hz), 4.78 – 4.68 (m, 1H), 4.60 
(s, 1H), 4.31 – 4.21 (m, 1H), 4.17 (dd, 1H, J = 9.1, 2.8 Hz), 3.28 (dd, 1H, J = 13.4, 
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3.2 Hz), 3.02 – 2.88 (m, 1H), 2.76 (dd, 1H, J = 13.3, 9.6 Hz), 2.40 (s, 1H), 1.82 (d, 3H, J 
= 1.8 Hz), 1.47 (d, 3H, J = 7.2 Hz), 1.36 (d, 3H, J = 7.2 Hz); 
13
C NMR (100 MHz, 
CDCl3): δ = 209.5, 170.7, 153.9, 135.2, 129.5, 129.2, 127.6, 82.7, 78.2, 66.6, 63.5, 55.4, 
52.0, 50.5, 38.1, 12.9, 12.2, 3.6; IR (film):   = 3511, 2940, 1775, 1716, 1690, 1454, 1357, 
1212, 1117, 998, 913, 762, 735, 703 cm
-1
; MS (EI) m/z (%): 357 (2), 339 (2), 311 (2), 
289 (40), 260 (17), 233 (30), 204 (1), 178 (29), 159 (3), 156 (5), 142 (19), 134 (38), 125 
(33), 117 (78), 112 (100), 107 (26), 101 (16), 97 (3), 91 (74), 86 (73), 83 (25), 79 (24), 77 
(13), 69 (32), 65 (19), 57 (89), 42 (30), 39 (28), 29 (26); HRMS (ESI): m/z: calcd. for 
C20H23NO5Na [M
+
 + Na]: 380.14685, found 380.14704.  
(S)-4-Benzyl-3-((2S,3R,4S,5R)-3,5-dihydroxy-2,4-dimethyloct-6-ynoyl)oxazolidin-2-
one (26a). Me4NBH(OAc)3 (3.72 g, 14.2 mmol) was dissolved 
in MeCN (260 mL) and HOAc (160 mL) and the resulting 
mixture cooled to ‒50 °C. A solution of compound 26 (1.01 g, 
2.83 mmol) in MeCN (34 mL) was added and the mixture 
warmed to +10 °C overnight. The mixture was then poured into 
a pre-cooled (0 °C) mixture of sat. aq. Rochelle salt (140 mL) and MTBE (140 mL). 
Under vigorous stirring, sat. aq. NaHCO3 and solid NaHCO3 were added in small 
portions until no further gas evolution was observed. The phases were separated and the 
aqueous layer was extracted with MTBE (4 x 100 mL). The combined organic layers 
were washed with brine, dried over MgSO4 and concentrated in vacuo to yield the desired 
diol (1.00 g, 98%) as a mixture of diastereomers (92:8 as determined by HPLC: 50 mm 
Ultra HAT Pro 18, 120 A, 2 m,  3.0 mm, MeOH/H2O = 60:40, 0.5 mL/min, 308 K, 
27.4 MPa). D20][  = + 36.0 (c =1.1, CHCl3); 
1
H NMR (400 MHz, CDCl3): δ = 7.35 – 7.25 
(m, 3H), 7.21 – 7.15 (m, 2H), 4.75 – 4.66 (m, 1H), 4.45 (s, 1H), 4.27 – 4.15 (m, 3H), 4.14 
– 4.01 (m, 1H), 3.89 – 3.76 (m, 2H), 3.22 (dd, 1H, J = 13.4, 3.4 Hz), 2.82 – 2.73 (m, 1H), 
2.06 – 1.93 (m, 1H), 1.84 (t, 3H, J = 3.6 Hz), 1.24 (dd, 3H, J = 13.8, 7.0 Hz), 0.91 – 0.83 
(m, 3H); 
13
C NMR (100 MHz, CDCl3): δ = 178.3, 152.9, 135.1, 129.6, 129.2, 127.7, 
82.1, 78.5, 73.9, 67.5, 66.4, 55.1, 39.9, 39.3, 38.0, 13.1, 9.9, 3.8; IR (film):  = 3417, 
2974, 2921, 1778, 1698, 1455, 1388, 1287, 978, 762, 702 cm
-1
; MS (EI) m/z (%): 359 (1), 
341 (3), 308 (1), 273 (68), 262 (7), 244 (3), 233 (38), 183 (3), 178 (50), 165 (14), 159 (4), 
149 (4), 142 (12), 136 (11), 134 (29), 126 (13), 117 (57), 109 (34), 103 (8), 96 (100), 91 
(71), 86 (74), 80 (44), 77 (11), 69 (35), 67 (11), 65 (17), 57 (51), 41 (32), 39 (18), 29 
(23), 27 (9); HRMS (ESI): m/z: calcd. for C20H25NO5Na [M
+





dimethyloct-6-ynoyl)oxazolidin-2-one (26b). Et3N (0.97 mL, 
4.20 mmol) and TBSOTf (0.78 mL, 5.6 mmol) were 
successively added to a solution of diol 26a (1.00 g, 
2.78 mmol) in CH2Cl2 (15 mL) at ‒78 °C. After stirring for 3 
h, the reaction was quenched with sat. aq. NaHCO3 and the resulting mixture warmed to 
room temperature. The aqueous layer was extracted with CH2Cl2 (3 x 15 mL), and the 
combined organic layers were washed with brine, dried over Na2SO4 and concentrated in 
vacuo. The residue was purified by flash chromatography (silica, hexanes/EtOAc, 9:1  
7:1) to yield the title compound as a colorless viscous liquid (1.17 g, single isomer, 89%). 
D
20][  = +36.8 (c = 1.64, CHCl3); 
1
H NMR (400 MHz, CDCl3): δ = 7.34 – 7.24 (m, 3H), 
7.23 – 7.17 (m, 2H), 4.73 – 4.62 (m, 2H), 4.26 – 4.05 (m, 3H), 3.91 (d, 1H, J = 2.0 Hz), 
3.85 (qd, 1H, J = 6.9, 2.4 Hz), 3.31 (dd, 1H, J = 13.3, 3.2 Hz), 2.74 (dt, 1H, J = 16.7, 
8.4 Hz), 1.86 – 1.73 (m, 4H), 1.26 – 1.18 (m, 3H), 0.95 (d, 3H, J = 7.0 Hz), 0.87 (s, 9H), 
0.12 (s, 3H), 0.11 (s, 3H); 
13
C NMR (100 MHz, CDCl3): δ = 176.7, 153.2, 135.5, 129.6, 
129.1, 127.4, 82.2, 78.7, 72.7, 66.6, 66.3, 55.7, 42.0, 40.5, 37.9, 25.9, 18.3, 11.9, 9.3, 3.7, 
‒4.4, ‒5.2; IR (film):   = 3509, 2928, 1782, 1702, 1680, 1455, 1387, 1360, 1285, 1242, 
1209, 1104, 1050, 1019, 984, 938, 836, 777, 702, 678 cm
-1
; MS (EI) m/z (%): 473 (M+, 
6), 416 (21), 398 (3), 348 (4), 341 (3), 337 (7), 336 (32), 324 (329, 318 (10), 306 (14), 
290 (5), 273 (8), 262 (4), 252 (44), 239 (14), 233 (14), 183 (100), 178 (41), 165 (5), 159 
(42), 147 (85), 143 (53), 136 (5), 133 (6), 127 (9), 119 (14), 117 (32), 115 (25), 109 (20), 
97 (14), 91 (27), 81 (8), 77 (6), 75 (72), 73 (49), 57 (11), 29 (5); HRMS (ESI): m/z: calcd. 
for C26H39NO3SiNa [M
+
 + Na]: 496.24897, found 496.24907.  
(2S,3R,4S,5R)-5-(tert-Butyldimethylsilyloxy)-3-hydroxy-N-methoxy-N,2,4-trimethyl-
oct-6-ynamide (26c). AlMe3 (2 M in heptane, 4.2 mL, 
8.31 mmol) was carefully added (exothermic reaction) to a 
solution of N,O-dimethylhydroxylamine hydrochloride 
(0.811 g, 8.31 mmol) in THF (7 mL) at 0 °C and the resulting suspension was stirred for 
15 min at this temperature and for 75 min at room temperature. The mixture was then 
cooled to ‒70 °C before a solution of compound 26b (1.05 g, 2.15 mmol) in THF 
(10 mL) was slowly added. The mixture was warmed to ‒10 °C over 8 h before it was 
poured into chilled (0 °C) sat. aq. Rochelle salt (300 mL). The resulting suspension was 
stirred for 45 min and then repeatedly extracted with CH2Cl2 (2x40 mL). The combined 
organic layers were washed with brine, dried over Na2SO4 and concentrated in vacuo. 
The residue was purified by flash chromatography (silica, hexanes/EtOAc, 6:1) to yield 
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the title compound as a colorless viscous liquid that solidified in the fridge (715 mg, 
93%). D20][  = +46.5 (c = 0.79, CHCl3); mp  13 °C; 
1
H NMR (400 MHz, CDCl3): δ 
= 4.86 – 4.82 (m, 1H), 4.05 (s, 1H), 3.75 (dd, 1H, J = 9.2, 2.4 Hz), 3.69 (s, 3H), 3.18 (s, 
3H), 3.06 – 2.92 (m, 1H), 1.80 (d, 3H, J = 2.2 Hz,), 1.73 – 1.63 (m, 1H), 1.11 (d, 3H, J = 
7.1 Hz,), 0.95 (d, 3H, J = 6.9 Hz,), 0.86 (s, 9H), 0.11 (s, 3H), 0.08 (s, 3H); 
13
C NMR (100 
MHz, CDCl3): δ = 178.5, 80.7, 80.4, 71.9, 63.3, 61.5, 42.4, 36.1, 32.2, 25.9, 18.3, 10.5, 
9.7, 3.6, ‒4.4, ‒5.1; IR (film):  = 3458, 2956, 2932, 2857, 1639, 1462, 1416, 1388, 1361, 
1292, 1251, 1178, 1146, 1113, 1056, 1016, 998, 863, 833, 776, 684 cm
-1
; MS (EI) m/z 
(%): 357 (1), 326 (2), 302 (3), 300 (47), 297 (13), 241 (9), 232 (3), 225 (6), 220 (34), 217 
(24), 208 (27), 183 (100), 174 (7), 164 (16), 159 (8), 153 (16), 143 (24), 138 (7), 127 (7), 
117 (30), 115 (42), 109 (17), 97 (19), 87 (9), 85 (11), 81 (12), 75 (90), 73 (64), 62 (8), 61 
(12), 59 (12), 45 (7), 41 (8), 29 (14); HRMS (ESI): m/z: calcd. for C18H35NO4SiNa [M
+
 + 
Na]: 380.22276, found 380.22281. 
(2S,3R,4S,5R)-5-(tert-Butyldimethylsilyloxy)-N-methoxy-3-(methoxymethoxy)-N,2,4-
trimethyloct-6-ynamide (26d). iPr2NEt (3.01 mL, 
18.2 mmol) and MOMCl (0.691 mL, 9.10 mmol) were added 
to a solution of alcohol 26c (650 mg, 1.82 mmol) in DMF 
(5 mL) and the resulting slightly fuming mixture stirred at 50 
°C for 18 h. After cooling, MTBE (20 mL) and brine (30 mL) were introduced and the 
aqueous layer was extracted with MTBE (3 x 15 mL). The combined organic layers were 
dried over Na2SO4 and concentrated in vacuo. The residue was purified by flash 
chromatography (silica, hexanes/EtOAc, 29:1  8:1) to yield product 26d as a colorless 
viscous liquid (651 mg, 89%). 
1
H NMR (400 MHz, CDCl3): δ = 4.64 – 4.43 (m, 3H), 
3.97 (dd, 1H, J = 8.8, 2.7 Hz), 3.65 (s, 3H), 3.31 (s, 3H), 3.15 (s, 3H), 2.96 (qd, 1H, J = 
6.9, 2.7 Hz), 1.80 (d, 3H, J = 2.2 Hz), 1.78 – 1.68 (m, 1H), 1.09 (d, 3H, J = 7.0 Hz), 0.98 
(d, 3H, J = 6.9 Hz), 0.86 (s, 9H), 0.12 (s, 3H), 0.08 (s, 3H); 
13
C NMR (100 MHz, 
CDCl3): δ = 176.4, 98.1, 81.0, 80.9, 79.7, 62.8, 61.0, 56.3, 44.3, 38.2, 25.9, 18.3, 11.0, 
9.7, 3.6, ‒3.9, ‒4.9; IR (film):  = 2931, 2890, 2857, 1672, 1463, 1408, 1377, 1250, 1168, 
1143, 1031, 1002, 940, 920, 834, 776, 673 cm–1; MS (EI) m/z (%): 370 (5), 357 (3), 356 
(12), 344 (51), 341 (10), 312 (6), 300 (5), 282(11), 274 (16), 271 (34), 260 (8), 253 (7), 
239 (10), 234 (14), 227 (15), 223 (18), 208 (32), 183 (62), 179 (25), 157 (19), 149 (12), 
127 (12), 119 (15), 115 (28), 105 (16), 97 (28), 89 (73), 73 (84), 59 (179, 45 (100), 29 
(6); HRMS (ESI): m/z: calcd. for C20H39NO5SiNa [M
+




When applied to 690 mg (1.92 mmol) of compound 26c this reaction yielded 760 mg 
(98%) of compound 26d. 
(3S,4R,5S,6R)-6-(tert-Butyldimethylsilyloxy)-4-(methoxymethoxy)-3,5-dimethylnon-
7-yn-2-one (27). MeMgCl (2.76 M in THF, 1.76 mL, 4.86 mmol) 
was added dropwise via syringe to a solution of compound 26d 
(650 mg, 1.62 mmol) in Et2O (15.0 mL) at 0 °C and the resulting 
mixture was stirred for 2 h. The reaction was quenched with brine 
(15 mL), the aqueous layer was extracted with Et2O (3 x 10 mL), and the combined 
organic layers were dried over Na2SO4 and concentrated in vacuo to yield the title 
compound as a colorless viscous liquid which was used as such in the next step (562 mg, 
97%, > 98% pure). An analytically pure sample was obtained by flash chromatography 
(hexanes/EtOAc, 29:1  8:1). D20][  = +64.1 (c = 0.88, hexanes); 
1
H NMR (300 MHz, 
CDCl3): δ = 4.65 – 4.43 (m, 3H), 4.03 (dd, 1H, J = 9.2, 1.9 Hz), 3.21 (s, 3H), 2.58 (qd, 
1H, J = 6.9, 1.8 Hz), 2.19 (s, 3H), 1.81 (d, 3H, J = 2.2 Hz), 1.79 – 1.70 (m, 1H), 1.05 (d, 
3H, J = 6.9 Hz,), 0.98 (d, 3H, J = 6.9 Hz), 0.88 (s, 9H), 0.14 (s, 3H), 0.09 (s, 3H); 
13
C 
NMR (75 MHz, CDCl3): δ = 210.4, 98.3, 81.8, 80.9, 80.3, 63.1, 56.3, 49.9, 44.5, 28.5, 
26.3, 18.6, 11.4, 8.6, 3.9, ‒3.4, ‒4.5; IR (film):  = 2931, 2857, 1716, 1462, 1360, 1251, 
1188, 1142, 1090, 1058, 1032, 918, 834, 777, 677 cm
-1
; MS (EI) m/z (%): 311 (1), 299 
(1), 293 (3), 255 (4), 239 (12), 237 (99, 229 (59, 227 (9), 225 (4), 197 (27), 183 (86), 163 
(46), 159 (27), 157 (15), 153 (15), 119 (19), 115 (18), 97 (21), 89 (57), 75 (55), 74 (6), 59 
(17), 45 (100), 43 (46), 41 (8); HRMS (ESI): m/z: calcd. for C19H36O5SiNa [M
+
 + Na]: 
379.22751, found 379.22734.  
When applied to 760 mg (1.89 mmol) of compound 26d this reaction yielded 665 mg 
(98%) of methyl ketone 27. 
(4S,5R,6S,7R)-7-(tert-Butyldimethylsilyloxy)-5-(methoxymethoxy)-3,4,6-trimethyl-
dec-1-en-8-yn-3-ol (28). Vinylmagnesium bromide (1.0 M in THF, 
3.15 mL, 3.15 mmol) was slowly added at –78 °C to a solution of 
ketone 27 (562 mg, 1.58 mmol) in THF (15 mL). The mixture was 
slowly warmed to room temperature (2 h) and stirred for additional 
2 h. Sat. aq. NH4Cl (25 mL) was then added and the aqueous layer extracted with Et2O (3 
x 12 mL). The combined organic layers were dried over Na2SO4 and concentrated in 
vacuo. The residue was purified by flash chromatography (silica, hexanes/EtOAc, 10:1 
 8:1) to yield alcohol 28 as a mixture of isomers (2:1, 1H NMR) (530 mg, 87%). D20][  
= +47.4 (c = 0.69, CHCl3); 
1
H NMR (300 MHz, CDCl3, data given for the major isomer): 
δ = 5.92 – 5.68 (m, 1H), 5.39 – 5.16 (m, 1H), 5.12 – 4.95 (m, 1H), 4.79 – 4.59 (m, 2H), 
S22 
 
4.56 – 4.44 (m, 1H), 4.05 – 3.78 (m, 2H), 3.37 (s, 3H), 1.89 – 1.76 (m, 3H), 1.76 – 1.52 
(m, 3H), 1.31 (s, 1H), 1.18 (d, 2H, J = 0.7 Hz), 1.03 ‒ 1.01 (m, 2H), 0.95 – 0.90 (m, 3H), 
0.89 – 0.83 (m, 9H), 0.16 – 0.05 (m, 6H); 13C NMR (75 MHz, CDCl3, data given for the 
major isomer): δ = 146.8, 111.7, 99.6, 82.8, 81.6, 80.6, 76.0, 63.2, 56.0, 44.6, 42.0, 27.4, 
26.0, 18.3, 11.4, 7.2, 3.6, ‒3.5, ‒4.7; IR (film):  = 3483, 2931, 2857, 1462, 1380, 1361, 
1250, 1209, 1143, 1032, 920, 833, 814, 776, 678 cm
-1
; MS (EI) m/z (%): 384, 339, 253 
(1), 215 (4), 185 (11), 183 (100), 157 (9), 143 (10), 127 (7), 119 (7), 115 (9), 97 (11), 89 
(22), 75 (24), 73 (37), 59 (6), 45 (34) ; HRMS (ESI): m/z: calcd. for C21H40O4SiNa [M
+
 + 
Na]: 407.25881, found 407.25918.  
When applied to 660 mg (1.89 mmol) of ketone 27 this reaction yielded 655 mg (92%) of 
compound 28. 
 (5S,6S,7R)-5-((R,E)-5-Bromo-3-methylpent-3-en-2-yl)-6,9,9,10,10-pentamethyl-7-
(prop-1-ynyl)-2,4,8-trioxa-9-silaundecane (29). Pyridine 
(0.32 mL, 3.92 mmol) was added at 0 °C to a solution of 
alcohol 28 (502 mg, 1.31 mmol) in Et2O (6.1 mL), followed 
by dropwise addition of PBr3 (1.0 M in toluene, 3.13 mL, 
3.13 mmol). The resulting mixture was stirred for 3 h at 0 °C before it was diluted with 
Et2O (20 mL). The reaction was carefully quenched with sat. aq. NaHCO3 (100 mL) and 
the aqueous layer extracted with Et2O (3 x 20 mL), the combined organic layers were 
dried over Na2SO4, filtered through a short pad of SiO2 and concentrated in vacuo. The 
residual allyl bromide was very sensitive and therefore immediately used in the next step 
(556 mg, 95%). 
1
H NMR (400 MHz, C6D6): δ = 5.49 – 5.42 (m, 1H), 4.95 (ddd, 1H, J = 
4.8, 2.3, 2.3 Hz), 4.60 (d, 1H, J = 6.6 Hz), 4.47 (d, 1H, J = 6.6 Hz), 3.75 (dd, 1H, J = 
8.4, 2.7 Hz), 3.66 (dd, 2H, J = 8.4, 2.1 Hz), 3.17 (s, 3H), 2.16 (dq, 1H, J = 6.8, 1.1 Hz), 
2.04 – 1.96 (m, 1H), 1.55 (d, 3H, J = 1.0 Hz), 1.50 (d, 3H, J = 2.2 Hz), 1.13 (d, 3H, J = 
6.8 Hz), 1.06 (s, 9H), 0.97 (d, 3H, J = 6.9 Hz), 0.36 (s, 3H), 0.28 (s, 3H); HRMS (ESI): 
m/z: calcd. for C21H39BrO3SiNa [M
+
+Na]: 469.17442, found 469.17489. 
When applied to 655 mg (1.70 mmol) of compound 28 this reaction yielded 633 mg 
(83%) of compound 29. 
(6R,7S,8S,9R,E)-Ethyl 9-(tert-butyldimethylsilyloxy)-7-(methoxymethoxy)-5,6,8-tri-
methyldodec-4-en-10-ynoate (29a). nBuLi (1.6 M in 
hexanes, 14.6 mL, 23.4 mmol) was added to a solution 
of iPr2NH (3.47 mL, 24.7 mmol) in THF (20 mL) at 
0 °C and the resulting mixture stirred for 1 h. In 
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parallel, CuI (8.90 g, 46.8 mmol) was suspended in THF (40 mL) and the suspension 
cooled to ‒110 °C (cooling bath: Et2O/CO2/N2). EtOAc (2.43 mL, 24.7 mmol) was added 
via syringe followed by dropwise addition of the freshly prepared LDA-solution via 
canula. The mixture was warmed over 3 h to ‒30 °C, inducing a color change of the 
slurry from grey to yellow-brown. A solution of allyl bromide 29 (580 mg, 1.30 mmol) in 
THF (5 mL) was then slowly introduced and the mixture stirred for 2.5 h. The suspension 
was then cooled to ‒60 °C before being quenched with aq. NH4Cl/NH4OH (9:1; 63 g 
NH4Cl, 17.5 mL 30% w/w aq. NH4OH, filled up to 350 mL with H2O). The aqueous layer 
was repeatedly extracted with MTBE, the combined organic layers were washed with 
brine, dried over Na2SO4 and concentrated in vacuo. The residue was purified by flash 
chromatography (silica, hexanes/EtOAc, 100:0  19:1) to yield the title compound as a 
light yellow viscous liquid (369 mg, 62%). D20][  = +16.0 (c = 0.24, CHCl3); 
1
H NMR 
(300 MHz, CDCl3): δ = 5.17 (t, 1H, J = 6.3 Hz), 4.56 (ddd, 1H, J = 5.6, 2.1, 2.0 Hz), 
4.52 (dd, 1H, J = 6.3 Hz), 4.43 (d, 1H, J = 6.3 Hz), 4.11 (q, 2H, J = 7.1 Hz), 3.61 (dd, 
1H, J = 7.8, 3.6 Hz), 3.32 (s, 3H), 2.31 (m, 4H), 2.26 – 2.17 (m, 1H), 1.80 (d, 3H, J = 
2.1 Hz), 1.78 – 1.71 (m, 1H), 1.64 (s, 3H), 1.24 (t, 3H, J = 7.1 Hz), 0.96 (dd, 6H, J = 6.9, 
4.7 Hz), 0.88 (s, 9H), 0.13 (s, 3H), 0.09 (s, 3H); 
13
C NMR (75 MHz, CDCl3): δ = 173.4, 
139.1, 123.3, 98.2, 81.3, 80.8, 80.7, 63.4, 60.4, 56.1, 44.5, 43.0, 34.4, 26.0, 23.8, 18.4, 
16.0, 14.4, 12.6, 11.2, 3.6, ‒3.9, ‒4.9; IR (film):  = 2956, 2929, 2857, 1727, 1462, 1374, 
1249, 1143, 1116, 1093, 1033, 919, 835, 814, 777, 676 cm
-1
; MS (EI) m/z (%): 439, 397 
(1), 365 (1), 329 (4), 283 (13), 253 (3), 211 (6), 183 (100), 169 (11), 157 (17), 115 (9), 95 
(17), 89 (17), 73 (29), 45 (31); HRMS (ESI): m/z: calcd. for C25H46O5SiNa [M
+
 + Na]: 
477.30067, found 477.30085.  
When applied to 630 mg (1.70 mmol) of compound 29 this reaction yielded 462 mg 
(70%) of ester 29a. 
(6R,7S,8S,9R,E)-9-(tert-Butyldimethylsilyloxy)-7-(methoxymethoxy)-5,6,8-trimethyl-
dodec-4-en-10-ynoic acid (5). TMSOK (593 mg, 
4.62 mmol) was added to a solution of ethyl ester 29a 
(420 mg, 924 µmol) in Et2O (55 mL). The suspension 
was stirred for 48 h before being diluted with sat. aq. 
NH4Cl (30 mL) and carefully acidified with HCl (1 M) to 
pH 4. The aqueous layer was extracted with EtOAc (3 x 30 mL) and the combined 
organic layers were washed with brine (30 mL), dried over Na2SO4 and concentrated in 
vacuo. The crude acid 5, obtained as a light yellow viscous liquid was judged pure and 
therefore used without further purification in the next step (390 mg, 98%). D20][  = +44.7 
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(c = 0.75, CHCl3); 
1
H NMR (400 MHz, CDCl3): δ = 11.5 – 9.5 (br s, 1H), 5.16 (t, 1H, J 
= 6.1 Hz), 4.56 – 4.53 (m, 1H), 4.52 (d, 1H, J = 6.3 Hz), 4.43 (d, 1H, J = 6.3 Hz), 3.60 
(dd, 1H, J = 7.8, 3.5 Hz), 3.32 (s, 3H), 2.42 – 2.29 (m, 4H), 2.28 – 2.20 (m, 1H), 1.80 (d, 
3H, J = 2.7 Hz), 1.78 – 1.71 (m, 1H), 1.64 (s, 3H), 0.97 (t, 6H, J = 7.2 Hz), 0.89 (s, 9H), 
0.12 (s, 3H), 0.08 (s, 3H); 
13
C NMR (100 MHz, CDCl3): δ = 178.8, 139.5, 122.9, 98.2, 
81.3, 80.9, 80.8, 63.4, 56.1, 44.5, 43.0, 34.0, 26.0, 23.5, 18.4, 16.0, 12.6, 11.3, 3.6, ‒3.9, 
‒4.9; IR (film):   = 3095, 2929, 2857, 2333, 2171, 1712, 1463, 1377, 1250, 1143, 1033, 
923, 834, 777, 676 cm
-1
; MS (EI) m/z (%): 411, 337 (1), 307 (3), 283 (12), 227 (6), 183 
(100), 173 (8), 157 (16), 154 (14), 115 (9), 97 (8), 89 (14), 75 (16), 73 (30), 45 (48); 
HRMS (ESI): m/z: calcd. for C23H42O5SiNa [M
+
 + Na]: 449.26937, found 449.26952. 
 




(3.44 mL, 19.7 mmol) was added to a cooled (0 °C) solution of ent-23 
(4.00 g, 17.1 mmol) and freshly distilled (nBu)2BOTf (7.38 mL, 
34.3 mmol) in Et2O (40 mL). After stirring for 45 min at 0 °C, the 
yellow suspension was cooled to ‒78 °C before a precooled (‒78 °C) 
solution of freshly distilled propionaldehyde (1.62 mL, 22.2 mmol) in 
Et2O (10 mL) was slowly introduced. After additional 30 min, the reaction was quenched 
by addition of solid tartaric acid (13 g) and the mixture stirred at room temperature for 2 
h. The reaction was partitioned between ether and H2O, and the combined organic layers 
were washed with sat. aq. NaHCO3 (2 x 40 mL). A mixture of MeOH/30% H2O2 (3:1, 
50 mL) was added under vigorous stirring at 0 °C and the resulting mixture stirred for 1 h 
at room temperature before it was extracted with Et2O (2 x 30 mL). The combined 
organic layers were washed with NaHCO3 and brine (30 mL each), dried over Na2SO4 
and concentrated in vacuo. The residue was purified by flash chromatography (silica, 
hexanes/EtOAc, 3:1) to yield the title compound as an off-white solid (3.69 g, 74%, 11:1 
dr.), along with additional 350 mg of mixed fractions. 
1
H NMR (400 MHz, CDCl3): δ = 
7.34 – 7.29 (m, 2H), 7.28 – 7.25 (m, 1H), 7.23 – 7.19 (m, 2H), 4.67 (ddd, 1H, J = 13.0, 
6.8, 3.2 Hz), 4.21 – 4.12 (m, 2H), 3.90 (dq, 1H, J = 6.9, 6.9 Hz), 3.65 (dddd, 1H, J = 8.3, 
8.3, 7.4, 3.5 Hz), 3.31 (dd, 1H, J = 13.5, 3.4 Hz), 2.76 (dd, 1H, J = 13.4, 9.6 Hz), 2.56 – 
2.52 (m, 1H), 1.73 – 1.63 (m, 1H), 1.54 – 1.41 (m, 1H), 1.20 (d, 3H, J = 6.9 Hz), 1.00 (t, 
3H, J = 7.4 Hz); 
13
C NMR (100 MHz, CDCl3): δ = 177.1, 153.7, 135.4, 129.6, 129.1, 
127.5, 76.2, 66.2, 55.7, 43.0, 38.0, 28.0, 14.8, 9.9; IR (film):  = 3516, 2967, 2936, 2879, 





MS (EI) m/z (%): 291 (10), 244 (28), 233 (18), 178 (32), 158 (15), 142 (13), 134 (24), 
133 (16), 118 (14), 117 (51), 116 (25), 115 (42), 97 (27), 96 (11), 92 (39), 91 (100), 86 
(87), 85 (25), 77 (11), 70 (13), 69 (37), 65 (29), 59 (57), 58 (19), 57 (89), 56 (24), 45 
(27), 43 (22), 42 (33), 41 (38), 39 (18), 31 (42), 30 (15), 29 (73), 28 (22), 27 (33); HRMS 
(EI): m/z: calcd. for C16H21NO4Na [M
+
+Na]: 314.13628, found 314.13570.  
(2R,3R)-1-((S)-4-Benzyl-2-oxooxazolidin-3-yl)-2-methyl-1-oxopentan-3-ylacetate 
(30). Et3N (2.20 mL, 15.8 mmol) and freshly distilled acetic anhydride 
(1.40 mL, 14.6 mmol) were successively added to a solution of the 
above alcohol (3.55 g, 12.1 mmol) in CH2Cl2 (36 mL). The mixture 
was cooled to 0 °C and DMAP (296 mg, 2.40 mmol) was introduced. 
After 30 min, the ice bath was removed and stirring continued for 90 
min before the reaction was quenched with sat. aq. NH4Cl (20 mL). The aqueous layer 
was extracted with CH2Cl2 (2 x 25 mL), the combined organic layers were washed with 
brine (30 mL), dried over Na2SO4 and concentrated in vacuo. The residue was purified by 
flash chromatography (silica, hexanes/EtOAc, 4:1  3:1) to yield the title compound as a 
single diastereomer in the form of a white solid (3.26 g, 82%). 
1
H NMR (400 MHz, 
CDCl3): δ = 7.35 – 7.29 (m, 2H), 7.28 – 7.25 (m, 1H), 7.22 – 7.18 (m, 2H), 5.23 (ddd, 
1H, J = 8.1, 8.0, 3.6 Hz), 4.70 – 4.63 (m, 1H), 4.20 – 4.10 (m, 3H), 3.25 (dd, 1H, J = 
13.1, 3.3 Hz), 2.68 (dd, 1H, J = 13.3, 9.7 Hz), 2.00 (s, 3H), 1.88 – 1.78 (m, 1H), 1.63 – 
1.52 (m, 1H), 1.17 (d, 3H, J = 7.1 Hz), 0.92 (t, 3H, J = 7.5 Hz); 
13
C NMR (100 MHz, 
CDCl3): δ = 174.7, 170.2, 153.1, 135.3, 129.5, 129.1, 127.5, 75.8, 66.0, 55.4, 40.9, 37.9, 
24.2, 21.1, 14.1, 8.9; IR (film):  = 3029, 2978, 2944, 2883, 1782, 1737, 1699, 1491, 
1455, 1378, 1349, 1291, 1208, 1111, 1098, 1049, 1016, 962, 884, 840, 762, 741, 726, 698 
cm
-1
; MS (EI) m/z (%): 273 (14), 244 (27), 178 (11), 157 (14), 117 (19), 97 (86), 96 (18), 
91 (32), 69 (23), 57 (10), 43 (100), 41 (16), 29 (13); HRMS (EI): m/z: calcd. for 
C18H23NO5Na [M
+
+Na]: 356.14684, found 356.14686. 
(5R,6R)-6-Ethyl-5-methyldihydro-2H-pyran-2,4(3H)-dione (9). A pre-cooled solution 
(‒78 °C) of LiHMDS (4.5 g, 27.0 mmol) in THF (50 mL) was added via 
canula to a solution of acetate 30 (3.00 g, 9.01 mmol) in THF (50 mL) at 
‒78 °C. After 1 h, the mixture was poured into sat. NH4Cl/H2O/MeOH 
(1:1:1, 250 mL) and diluted with EtOAc (150 mL). The organic layer 
containing the chiral auxiliary was separated, which could be recovered by flash 
chromatography (hexanes/EtOAc, 1:1). The aqueous layer was acidified with aq. HCl (1 
M) to pH 2 and then extracted with CH2Cl2 (3 x 60 mL). The combined organic layers 
were dried over Na2SO4 and concentrated in vacuo. The residue was purified by flash 
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chromatography (silica, hexanes/EtOAc, 3:1  1:1) to yield the desired ß-ketoester as a 
white solid (1.17 g, 83%). D20][  = ‒14.4 (c = 0.55, Et2O); 
1
H NMR (400 MHz, CDCl3): δ 
= 4.25 (ddd, 1H, J = 10.5, 7.6, 3.0 Hz), 3.53 (d, 1H, J = 19.1 Hz), 3.41 (d, 1H, J = 
19.2 Hz), 2.40 (dq, 1H, J = 10.4, 7.1 Hz), 1.93 (tdd, 1H, J = 14.8, 7.3, 3.0 Hz), 1.69 (qdd, 
1H, J = 14.7, 7.4, 7.3 Hz), 1.15 (d, 3H, J = 7.1 Hz), 1.08 (t, 3H, J = 7.3 Hz); 
13
C NMR 
(100 MHz, CDCl3): δ = 202.9, 167.4, 81.4, 46.5, 45.9, 25.5, 10.8, 8.6; IR (neat):   = 
3205, 2969, 2928, 2763, 2346, 1652, 1587, 1450, 1395, 1376, 1323, 1275, 1260, 1220, 
1152, 1127, 1084, 1055, 1039, 991, 964, 903, 872, 850, 823, 750, 697 cm
-1
; MS (EI) m/z 
(%): 156 (12), 127 (20), 98 (70), 97 (14), 85 (58), 70 (29), 69 (16), 57 (35), 56 (100), 55 
(34), 43 (12), 42 (41), 31 (18), 39 (13), 29 (35), 28 (25), 27 (20); HRMS (EI): m/z: calcd. 
for C8H12O3 [M]: 156.07865, found 156.07866. 
Alternative synthesis of homoallylic alcohol 8. A flame-dried microwave tubular vessel 
was charged with (R)-3,3’-dibromo-1,1’-bi-2-naphthol ((R)-34) (8.89 
mg, 20.0 µmol) and toluene (0.67 mL) and B-allyl-1,3,2-
dioxaborinane (32) (37.8 mg, 300 µmol) were then added. The 
mixture was stirred at room temperature for 5 min. Then β-ketoester 9 
(31.3 mg, 200 µmol) was added and the reaction mixture submitted to microwave 
irradiation. The external reaction vessel temperature was measured via IR temperature 
probe and maintained at 130 °C for 3 h. After cooling to room temperature the solvent 
was concentrated in vacuo and the residue purified by flash chromatography (silica, 
hexanes/EtOAc, 4:1  2:1) to yield the desired isomer as a colorless liquid (33.6 mg, 
85%). 
1
H NMR analysis of the crude product before flash chromatography indicated a 
diastereomeric ratio of 6.1:1 in favor of compound 8. D20][  = +1.8 (c = 0.56, CHCl3); 
1
H 
NMR (400 MHz, C6D6): δ = 5.70 (dddd, 1H, J = 17.1, 10.1, 7.5, 7.1 Hz), 5.02 (dddd, 1H, 
J = 10.1, 1.9, 0.9, 0.8 Hz), 4.95 (ddd, 1H, J = 17.1, 3.3, 1.4 Hz), 3.44 (ddd, 1H, J = 10.2, 
7.4, 2.9 Hz), 2.57 (d, 1H, J = 16.4 Hz), 2.18 (dd, 1H, J = 16.5, 1.1 Hz), 1.98 (ddq, 1H, J 
= 13.9, 6.8, 1.1 Hz), 1.90 (br s, 1H), 1.78 – 1.71 (m, 1H), 1.55 (dq, 1H, J = 10.1, 6.9 Hz), 
1.51 – 1.41 (m, 1H), 1.32 – 1.21 (m, 1H), 0.90 (t, 3H, J = 7.3 Hz), 0.57 (d, 3H, J = 
6.9 Hz); 
13
C NMR (100 MHz, C6D6): δ = 168.4, 132.2, 120.2, 82.5, 71.0, 43.1, 42.9, 38.9, 
27.0, 10.7, 9.1; IR (neat):  = 3434, 3078, 2974, 2939, 1721, 1640, 1463, 1377, 1247, 
1163, 1085, 1042, 1006, 919, 838, 796 cm
-1
; MS (EI) m/z (%): 157 (25), 127 (9), 111 (9), 
99 (45), 98 (11), 95 (37), 71 (100), 67 (14), 57 (37), 55 (35), 53 (29), 43 (60), 42 (43), 41 
(96), 40 (13), 39 (44), 29 (73), 27 (42); HRMS (EI): m/z: calcd. for C11H18O3Na 
[M
+
+Na]: 221.11481, found 221.11457. The analytical and spectroscopic data are in 





Alternative synthesis of homoallylic alcohol epi-8. Prepared analogously from -
ketoester 9, B-allyl-1,3,2-dioxaborinane (32) and (S)-3,3’-dibromo-
1,1’-bi-2-naphthol ((S)-34) and tert-butanol (38 μL, 400 μmol). The 
residue was purified by flash chromatography (silica, hexanes/EtOAc, 
4:1  2:1) to yield the desired isomer as a white solid (26.7 mg, 
68%). 
1
H NMR analysis of the crude product before flash chromatography indicated a 
diastereomeric ratio of 9.0:1 in favor of compound epi-8. D20][  = +4.4 (c = 0.88, MeCN); 
1
H NMR (500 MHz, C6D6): δ = 5.45 (dddd, 1H, J = 17.1, 9.9, 7.3, 7.3 Hz), 4.94 (dddd, 
1H, J = 10.1, 1.7, 0.7, 0.7 Hz), 4.88 (ddd, 1H, J = 17.0, 3.2, 1.3 Hz), 4.21 (ddd, 1H, J = 
10.5, 7.7, 2.8 Hz), 2.48 (d, 1H, J = 17.3 Hz), 2.38 (br s, 1H), 2.21 (d, 1H, J = 17.3 Hz), 
2.00 (dd, 1H, J = 13.7, 7.3 Hz), 1.90 (dd, 1H, J = 13.7, 7.6 Hz), 1.59 – 1.50 (m, 1H), 
1.19 – 1.29 (m, 2H), 0.91 (t, 3H, J = 7.3 Hz), 0.63 (d, 3H, J = 6.7 Hz); 13C NMR (100 
MHz, C6D6): δ = 169.1, 132.5, 120.1, 82.8, 71.1, 43.1, 43.1, 39.2, 27.0, 10.9, 9.2; IR 
(film):  = 3429, 2978, 2935, 1710, 1460, 1442, 1385, 1326, 1261, 1107, 1008, 987, 919, 
702 cm
-1
; MS (EI) m/z (%): 157 (26), 127 (9), 111 (9), 99 (45), 98 (12), 95 (37), 71 (100), 
67 (16), 57 (37), 55 (30), 53 (29), 43 (60), 42 (43), 41 (96), 40 (13), 39 (44), 29 (73), 27 
(43); HRMS (EI): m/z: calcd. for C11H18O3Na [M
+
+Na]: 221.11481, found 221.11461. 
Homopropargylic alcohol 31. A flame-dried microwave tubular vessel was charged 
with (R)-3,3’-dibromo-1,1’-bi-2-naphthol ((R)-34) (44.5 mg, 
100 µmol) and toluene (3.0 mL) and B-allenyl-1,3,2-dioxaborinane 
(33) (186 mg, 1.50 mmol) were then added. The mixture was stirred at 
room temperature for 5 min. Then β-ketoester 9 (157 mg, 1.0 mmol) 
was added and the reaction mixture submitted to microwave irradiation. The external 
reaction vessel temperature was measured via IR temperature probe and maintained at 
130 °C for 3 h. After cooling to room temperature the solvent was concentrated in vacuo 
and the residue purified by flash chromatography (silica, hexanes/MTBE, 1:1) to yield 
the desired isomer as a colorless viscous liquid (171 mg, 87%). 
1
H NMR analysis of the 
crude product before flash chromatography indicated a diastereomeric ratio of 7.6:1 in 
favor of compound 31. D20][  = ‒33.1 (c = 1.00, CHCl3); 
1
H NMR (400 MHz, CDCl3): δ 
= 3.91 (ddd, J = 10.3, 7.4, 3.2 Hz, 1H), 2.97 (d, J = 16.8 Hz, 1H), 2.57 – 2.52 (m, 1H), 
2.52 – 2.49 (m, 1H), 2.49 (br s, 1H), 2.34 (dd, J = 16.7, 2.6 Hz, 1H), 2.15 (t, J = 2.6 Hz, 
1H), 1.98 (dq, J = 10.1, 6.9 Hz, 1H), 1.84 (dqd, J = 14.9, 7.4, 3.2 Hz, 1H), 1.68 – 1.55 
(m, 1H), 1.02 (d, J = 6.9 Hz, 3H), 1.00 (d, J = 7.4 Hz, 3H); 
13
C NMR (100 MHz, 
CDCl3): δ = 170.1, 83.4, 78.6, 73.5, 71.0, 42.8, 41.8, 26.8, 26.7, 11.4, 9.0; IR (film):   = 
3423, 3286, 2973, 2939, 2883, 2122, 1713, 1462, 1427, 1378, 1326, 1247, 1209, 1161, 
S28 
 
1133, 1059, 1009, 994, 951, 790, 645 cm
-1
; HRMS (ESIpos): m/z: calcd. for C11H16O3Na 
[M
+
+Na]: 219.09916, found 219.09950. 
Homopropargylic alcohol epi-31. Prepared analogously from -
ketoester 9 (31.3 mg, 200 μmol), B-allenyl-1,3,2-dioxaborinane (33) 
(37.2 mg, 300 μmol) and (S)-3,3’-dibromo-1,1’-bi-2-naphthol ((S)-34) 
(8.9 mg, 20 µmol) to yield the desired isomer (34.1 mg, 87%) as a 
white crystalline solid. 
1
H NMR analysis of the crude product before flash 
chromatography indicated a diastereomeric ratio of 15:1 in favor of compound epi-31. A 
crystal suitable for X-ray analysis was obtained by slowly concentrating a solution of the 
title compound in hexanes/CH2Cl2 (2:3). 
D
20][  = ‒47.4 (c = 1.00, CHCl3); 
1
H NMR (400 
MHz, CDCl3): δ = 4.29 (ddd, J = 10.4, 7.3, 2.9 Hz, 1H), 2.73 (s, 2H), 2.54 – 2.43 (br s, 
1H), 2.49 (dd, J = 16.7, 2.7 Hz, 1H), 2.41 (dd, J = 16.7, 2.7 Hz, 1H), 2.10 (t, J = 2.7 Hz, 
1H), 1.93 – 1.80 (m, 2H), 1.57 (dqd, J = 14.5, 7.3, 2.9 Hz, 1H), 1.01 (d, J = 7.3 Hz, 3H), 
0.97 (d, J = 6.8 Hz, 3H); 
13
C NMR (100 MHz, CDCl3): δ = 170.8, 82.6, 78.8, 72.5, 71.3, 
42.7, 38.4, 30.4, 26.0, 9.7, 8.8; IR (film):   = 3391, 3292, 3264, 2977, 2935, 2882, 1702, 
1459, 1435, 1387, 1325, 1254, 1209, 1166, 1124, 1082, 1060, 1039, 1010, 989, 954, 895, 
786, 688, 645, 596, 438 cm
-1
; HRMS (ESIpos): m/z: calcd. for C11H16O3Na [M
+
+Na]: 
219.09916, found 219.09960. 
Vinyl stannane 35. CH2Cl2 used for the hydrostannation was degassed by Ar bubbling 
for 30 min prior to use. iPr2NEt (17 µL, 93.8 µmol) was 
added to a solution of Pd2(dba)3 (10.8 mg, 11.7 µmol) and 
Cy3P•HBF4 (17.3 mg, 46.9 µmol) in CH2Cl2 (6.0 mL) and 
the mixture was stirred at room temperature for 20 min, 
turning from dark red to light yellow. Subsequently, homopropargylic alcohol 31 
(230 mg, 1.17 mmol) was added, followed by a solution of freshly distilled (nBu)3SnH 
(347 µL, 1.29 mmol) in CH2Cl2 (11.0 mL) added over 10 min. The reaction mixture was 
stirred at room temperature for 20 min and then concentrated in vacuo. The residue was 
purified by flash chromatography (silica, hexanes/MTBE, 5:1  1:1, toluene deposit) to 
yield the title compound as a colorless viscous liquid (411 mg, 72%). D20][  = ‒7.3 (c = 
1.00, CHCl3); 
1
H NMR (400 MHz, CDCl3): δ = 6.18 (d, J = 18.8 Hz, 1H), 5.97 (ddd, J = 
18.8, 7.4, 6.3 Hz, 1H), 3.93 (ddd, J = 10.3, 7.3, 3.1 Hz, 1H), 2.78 (d, J = 16.8 Hz, 1H), 
2.38 (d, J = 16.8 Hz, 1H), 2.34 (dd, J = 13.5, 7.4 Hz, 1H), 2.28 (dd, J = 13.5, 6.3 Hz, 
1H), 1.98 (s, 1H), 1.96 – 1.89 (m, 1H), 1.85 (ddd, J = 14.5, 7.4, 3.1 Hz, 1H), 1.67 – 1.53 
(m, 1H), 1.52 – 1.42 (m, 6H), 1.36 – 1.22 (m, 6H), 1.02 (d, J = 7.4 Hz, 3H), 1.01 (d, J = 
6.8 Hz, 3H), 0.92 – 0.80 (m, 15H); 13C NMR (100 MHz, CDCl3): δ = 169.7, 140.5, 137.1, 
S29 
 
82.8, 70.0, 42.3, 42.1, 41.6, 28.4, 28.4, 28.4, 26.5, 26.5, 26.5, 26.0, 13.0, 13.0, 13.0, 10.4, 
8.8, 8.8, 8.8, 8.1; IR (film):  = 3434, 2955, 2923, 2872, 2851, 1719, 1597, 1462, 1376, 
1243, 1212, 1070, 1043, 997, 959, 873, 776, 690, 662, 631, 595, 506 cm
-1
; MS (ESIpos) 
m/z 511.2 [M
+






Diyne 4. EDCI·HCl (83.1 mg, 433 µmol) was added to a solution of alcohol 6 (114 mg, 
393 µmol) in CH2Cl2 (2.8 mL) and the resulting mixture 
cooled to 0 °C. Then, DMAP (52.9 mg, 433 µmol) was 
introduced in three portions and the mixture stirred for 10 
min before a solution of acid 5 (185 mg, 433 µmol) in 
CH2Cl2 (2.5 mL) was slowly added. Stirring was 
continued for 30 min at 0 °C before the ice bath was 
removed. After 5 h at room temperature, the mixture was poured into brine (10 mL) and 
diluted with CH2Cl2 (5 mL). The aqueous layer was extracted with CH2Cl2 (3 x 8 mL), 
the combined organic layers were dried over Na2SO4 and concentrated in vacuo. The 
residue was purified by flash chromatography (silica, hexanes/EtOAc, 29:1  19:1) to 
yield the title compound as a colorless viscous liquid (244 mg, 89%). D20][  = +80.9 (c = 
1.0, CHCl3); 
1
H NMR (400 MHz, CDCl3): δ = 6.26 (s, 1H), 5.56 (dd, 1H, J = 10.1, 
10.0 Hz), 5.43 (dq, 1H, J = 10.7, 2.2 Hz), 5.19 (1H, d, J = 7.4 Hz), 5.16 – 5.10 (br t, 1H), 
4.56 – 4.52 (m, 1H), 4.51 (d, 1H, J = 6.3 Hz), 4.43 (d, 1H, J = 6.2 Hz), 3.60 (dd, 1H, J = 
7.7, 3.6 Hz), 3.32 (s, 3H), 3.12 (ddq, 1H, J = 9.3, 7.1, 7.1 Hz), 2.37 – 2.27 (m, 4H), 2.27 
– 2.19 (m, 1H), 1.96 (d, 3H, J = 2.2 Hz), 1.83 (d, 3H, J = 0.8 Hz), 1.80 (d, 3H, J = 
2.1 Hz), 1.79 – 1.73 (m, 1H), 1.63 (s, 3H), 0.97 (d, 3H, J = 6.8 Hz), 0.96 (d, 3H, J = 
6.9 Hz), 0.92 (d, 3H, J = 6.9 Hz), 0.87 (s, 9H), 0.12 (s, 3H), 0.08 (s, 3H); 
13
C NMR (100 
MHz, CDCl3): δ = 172.3, 144.8, 142.2, 139.2, 123.2, 111.2, 98.1, 90.5, 81.3, 80.9, 80.9, 
80.6, 80.2, 76.2, 63.4, 56.1, 44.5, 43.0, 37.3, 34.5, 26.0, 23.8, 20.7, 18.4, 16.9, 16.0, 12.7, 
11.2, 4.6, 3.6, ‒3.9, ‒4.9; IR (film):  = 2955, 2928, 2856, 1738, 1618, 1461, 1376, 1248, 
1142, 1117, 1091, 1075, 1061, 1031, 938, 920, 833, 775, 675 cm
-1
; MS (EI) m/z (%): 458 
(5), 283 (28), 185 (16), 184 (16), 183 (100), 174 (5), 169 (26), 163 (5), 159 (6), 157 (15), 
153 (12), 146 (40), 145 (17), 137 (11), 131(29), 115 (7), 97 (6), 93 (8), 91 (8), 89 (16), 82 






When applied to 285 mg (982 µmol) of compound 6 this reaction yielded 653 mg (96%) 
of compound 4. 
Macrocyle 3. All glassware used for the ring closing alkyne metathesis reaction was 
flame-dried under vacuum and backfilled with Ar after 
cooling to room-temperature (3 cycles). All solvents used 
were freshly distilled (toluene from Na/K, CH2Cl2 from 
CaH2), stored over 4Å MS and degassed by 4 freeze-
pump-thaw cycles prior to use. A stock solution of 
activated catalyst was prepared as follows: CH2Cl2 (205 µL, 3.26 mmol) was added to a 
solution of complex 11 (80.0 mg, 128 µmol)
9,10
 in toluene (6.4 mL). The resulting brown 
solution was stirred for 30 min to give a 0.0194 M stock solution of the active catalyst. 
Diyne 4 (150 mg, 215 µmol) was azeotropically dried with toluene (3 x 2 mL). It was 
then transferred as a toluene solution to a two-necked round-bottom flask equipped with a 
reflux condenser and septum. Additional toluene was added to reach a total volume of 
150 mL. The solution was heated to 100 °C and an aliquot of the activated catalyst 
solution (3.30 mL, 65.0 µmol, 0.30 eq.) was introduced via syringe. The reaction was 
stirred at 100 °C for 7 h before a second aliquot of the catalyst solution (0.11 mL, 
22.0 µmol, 0.10 eq.) was added. Stirring was continued at 100 °C for further 12 h. After 
reaching room temperature, the mixture was diluted with Et2O (200 mL) to slowly form a 
brown precipitate which was filtered off through a short pad of SiO2, eluting with Et2O 
(250 mL). The light brown filtrate was concentrated in vacuo. The residue was purified 
by flash chromatography (silica, hexanes/EtOAc, 39:1  19:1) to yield a mixture of N-
tert-butyl-3,5-dimethylaniline and the desired product. The amine was removed at 60 °C 
under high vacuum overnight to leave the title compound as a light yellow viscous liquid 
(99.2 mg, 72%). D20][  = +83.0 (c = 0.57, n-hexane); 
1
H NMR (400 MHz, CDCl3): δ = 
6.34 (d, 1H, J = 1.0 Hz), 5.63 (dd, 1H, J = 10.6, 9.6 Hz), 5.54 (dd, 1H, J = 10.6, 1.6 Hz), 
5.36 – 5.30 (m, 1H), 5.24 (d, 1H, J = 9.6 Hz); 4.73 (d, 1H, J = 6.8 Hz), 4.62 (d, 1H, J = 
6.8 Hz), 4.37 (dd, 1H, J = 9.1, 1.1 Hz), 3.43 (d, 1H, J = 9.2 Hz), 3.39 (s, 3H), 3.17 (dddd, 
1H, J = 16.5, 9.7, 6.9, 6.8 Hz), 2.98 – 2.88 (m, 1H), 2.45 – 2.36 (m, 1H), 2.35 – 2.19 (m, 
3H), 2.07 (dddd, 1H, J = 15.5, 7.2, 7.2, 0.6 Hz), 1.83 (d, 3H, J = 1.0 Hz), 1.48 (s, 3H), 
1.07 (d, 3H, J = 7.1 Hz), 1.00 (d, 3H, J = 7.0 Hz), 0.89 (s, 9H), 0.82 (d, 3H, J = 6.9 Hz), 
0.11 (s, 3H), 0.07 (s, 3H); 
13
C NMR (100 MHz, CDCl3): δ = 172.0, 144.7, 144.5, 137.6, 
126.6, 110.5, 99.1, 97.1, 87.2, 82.6, 82.1, 80.7, 64.1, 56.2, 46.2, 42.2, 37.9, 34.7, 25.9, 
22.7, 19.7, 18.3, 17.6, 16.5, 12.3, ‒4.3, ‒4.9; IR (film):  = 2957, 2929, 2856, 1732, 1617, 





MS (pos. ESI) m/z (%): 683 (M+K, 30), 667 (M+Na, 100); HRMS (EI): m/z: calcd. for 
C30H49IO5SiNa [M
+
+Na]: 667.22862, found 667.22903. 
When applied to 295 mg (422 µmol) of compound 4 this reaction yielded 195 mg (72%) 
of compound 3. 
 
Completion of the Total Synthesis (Route A) 
Alternative synthesis of silyl ether 39a. DMF used for the Stille-Migita cross coupling 
was degassed by Ar bubbling for 30 min 
prior to use. Tetra-n-butylammonium 
diphenylphosphinate was melted and 
allowed to return to room temperature 
under high vacuum (10
−2
 mbar) twice 
prior to use. A solution of vinyl iodide 3 (100 mg, 155 µmol) and vinyl stannane 35 (106 
mg, 217 µmol) in DMF (3.2 mL) was added to a Schlenk tube containing flame-dried 
[(nBu4N)(Ph2PO2)] (107 mg, 233 µmol). Copper-thiophene carboxylate complex (CuTC, 
47.3 mg, 248 µmol) was then introduced followed by Pd(PPh3)4 (9.0 mg, 7.75 µmol) 
inducing color changes of the reaction mixture from yellow to orange and dark green 
respectively. The reaction mixture was then stirred at room temperature for 1 min before 
being quenched with H2O (10 mL). The aqueous layer was extracted with Et2O (5 x 20 
mL), the combined organic layers were dried over Na2SO4 and concentrated in vacuo. 
The residue was purified by flash chromatography (silica, hexanes/EtOAc, 5:1  3:1) to 
yield the title compound as a yellow solid (103 mg, 93%). D20][  = +117.3 (c = 0.88, 
CHCl3); 
1
H NMR (500 MHz, CDCl3): δ = 6.31 (dd, 1H, J = 15.0, 10.9 Hz), 6.01 (d, 1H, J 
= 11.0 Hz), 5.70 (ddd, 1H, J = 15.0, 7.5, 7.5 Hz), 5.65 (dd, 1H, J = 10.3, 10.2 Hz), 5.52 
(dd, 1H, J = 10.8, 0.9 Hz), 5.37 – 5.32 (m, 1H), 5.07 (d, 1H, J = 9.8 Hz), 4.71 (d, 1H, J = 
6.8 Hz), 4.61 (d, 1H, J = 6.8 Hz), 4.35 (d, 1H, J = 8.8 Hz), 3.92 (ddd, 1H, J = 10.0, 7.3, 
2.9 Hz), 3.41 (br d, 1H, J = 7.6 Hz), 3.38 (s, 3H), 3.24 – 3.13 (m, 1H), 3.00 – 2.80 (br s, 
1H), 2.77 (d, 1H, J = 16.7 Hz), 2.45 – 2.37 (m, 2H), 2.35 (d, 1H, J = 16.7 Hz), 2.33 – 
2.24 (m, 2H), 2.23 – 2.12 (m, 2H), 2.08 (ddd, 1H, J = 15.4, 7.6, 7.5 Hz), 1.90 (ddd, 1H, J 
= 16.8, 6.9, 6.9 Hz), 1.83 (ddq, 1H, J = 14.7, 7.3, 2.8 Hz), 1.73 (s, 3H), 1.60 (ddq, 1H, J 
= 14.7 Hz, 7.3, 7.3 Hz), 1.45 (s, 3H), 1.06 (d, 3H, J = 7.1 Hz), 1.02 – 0.97 (m, 9H), 0.87 
(s, 9H), 0.80 (d, 3H, J = 6.9 Hz), 0.09 (s, 3H), 0.06 (s, 3H); 
13
C NMR (125 MHz, 
CDCl3): δ = 172.4, 170.4, 145.3, 137.2, 134.2, 131.6, 129.0, 127.6, 126.9, 110.0, 99.1, 
96.7, 87.3, 83.8, 82.7, 82.3, 71.7, 64.1, 56.1, 46.2, 42.8, 42.7, 42.0, 38.0, 37.7, 34.8, 26.9, 
S32 
 
25.9, 22.6, 18.3, 17.5, 17.0, 16.7, 12.3, 12.1, 11.3, 9.1, ‒4.3, ‒5.0; IR (film):  = 3448, 
2961, 2930, 2857, 1724, 1462, 1377, 1248, 1144, 1058, 1032, 1004, 983, 919, 858, 835, 
750, 667 cm
-1
; MS (EI) m/z (%): 714 (5), 696 (4), 657 (4), 425 (5), 381 (13), 357 (8), 325 
(7), 299 (9), 267 (12), 249 (27), 222 (72), 173 (11), 171 (14), 169 (68), 159 (11), 157 
(16), 145 (13), 143 (11), 137 (18), 133 (18), 119 (17), 107 (16), 95 (25), 89 (36), 81 (20), 
75 (41), 73 (100), 72 (24); HRMS (EI): m/z: calcd. for C41H66O8SiNa [M
+
+Na]: 
737.44119, found 737.44102. 
Propargylic alcohol 39a. TBAF (1 M in THF, 92.6 µL, 93.0 µmol) was slowly added to 
a suspension of silyl ether 39 (26.5 mg, 
37.0 µmol) and activated 4Å molecular 
sieves (powder) in THF (0.5 mL) at 0 °C. 
After 40 min, the reaction was quenched 
with H2O/brine (2:1, 4 mL) and diluted 
with EtOAc (3 mL). The aqueous layer was extracted with EtOAc (3 x 4 mL) and the 
combined organic layers were dried over Na2SO4 and concentrated in vacuo. The residue 
was quickly purified by flash chromatography (Florisil
®
, hexanes/EtOAc, 2:1  1:2), 
keeping the contact time with the stationary phase as short as possible. The white solid 
(19.2 mg, 85%) thus obtained was immediately used in the next step as it decomposes 
upon storage in a freezer. 
1
H NMR (400 MHz, C6D6): δ = 6.36 (dd, 1H, J = 14.9, 
10.8 Hz), 6.15 (d, 1H, J = 10.8 Hz), 5.73 (dt, 1H, J = 15.0, 7.5 Hz), 5.53 – 5.46 (m, 3H), 
5.41 – 5.35 (m, 1H), 5.08 (br t, 1H, J = 2.7 Hz), 4.41 (s, 2H), 3.52 (ddd, 1H, J = 10.0, 
7.4, 2.8 Hz), 3.42 (dd, 1H, J = 8.6, 2.5 Hz), 3.36 – 3.26 (m, 1H), 3.12 (s, 3H), 3.12 – 3.10 
(m, 1H), 2.65 (d, 1H, J = 16.4 Hz), 2.56 (dq, 1H, J = 7.4, 7.3 Hz), 2.30 – 2.15 (m, 6H), 
2.14 – 2.02 (m, 2H), 1.93 (dd, 1H, J = 14.3, 7.7 Hz), 1.74 (s, 3H), 1.61 (dd, 1H, J = 15.9, 
9.1, 6.9, 2.2 Hz), 1.50 (ddq, 1H, J = 14.6, 7.2, 3.1 Hz), 1.41 (s, 3H), 1.33 – 1.23 (m, 1H), 
1.32 (d, 3H, J = 7.1 Hz), 1.01 (d, 3H, J = 7.0 Hz), 0.93 (d, 3H, J = 6.9 Hz), 0.91 (t, 3H, J 
= 7.3 Hz), 0.67 (d, 3H, J = 6.8 Hz); IR (film):   = 3454, 2972, 2932, 1727, 1462, 1379, 
1246, 1193, 1151, 1090, 1029, 1022, 986, 844, 759 cm
-1
; HRMS (ESIpos): m/z: calcd. for 
C35H52O8Na [M
+
+Na]: 623.35544, found 623.35513. 
When applied to 80.1 mg (112 µmol) of compound 39 this reaction yielded 54.5 mg 
(81%) of compound 39a. 
Allylic alcohol 40. A solution of 
propargyl alcohol 39a (14.0 mg, 
241 µmol) in THF (0.3 mL) was added to 





 (1.3 g) in degassed MeOH/H2O (1:1, 1.1 mL) and the resulting mixture was 
stirred at 50 °C for 18 h. After cooling to room-temperature, the mixture was diluted with 
EtOAc (5 mL) and filtered through a short pad of Celite
®
, which was carefully rinsed 
with EtOAc (140 mL) and EtOH (15 mL). The combined filtrates were concentrated in 
vacuo to ca. 1/10 of the original volume and then washed with brine/H2O (1:1, 15 mL). 
The aqueous layer was extracted with EtOAc (2 x 15 mL), the combined organic layers 
were dried over Na2SO4 and concentrated in vacuo. The residue was purified by flash 
chromatography (Florisil
®
, hexanes/EtOAc, 2:1  1:1) to yield the title compound as a 
white solid (12.9 mg, 89%). D20][  = ‒72.0 (c = 0.66, CH2Cl2); 
1
H NMR (600 MHz, 
CD2Cl2): see Table S-1; 
13
C NMR (150 MHz, CD2Cl2): see Table S-1; IR (film):   = 
3447, 2966, 2932, 1729, 1456, 1415, 1368, 1243, 1206, 1147, 1089, 1020, 985, 918, 863, 
783, 748, 736, 700 cm
-1
; HRMS (ESIpos): m/z: calcd. for C35H54O8Na [M
+
+Na]: 
625.37109, found 625.37092. 
When applied to 54.5 mg (90.7 µmol) of compound 39a this reaction yielded 50.2 mg 
(92%) of compound 40. 
Allylic carbamate 41. A solution of trichloroacetyl isocyanate (1.0 M in CH2Cl2, 
16.4 µL, 16.4 µmol) was added to a 
precooled solution (‒78 °C) of the allylic 
alcohol 40 (9.0 mg, 15.0 µmol) in CH2Cl2 
(500 µL). The mixture was stirred at ‒78 
°C for 2 h, before being quenched with 
MeOH (100 µL) at this temperature. After 
warming and concentration in vacuo, the residue was dissolved in CH2Cl2 (1 mL) and the 
solution soaked on basic alumina. After 1.5 h, the alumina was loaded onto a short pad of 
Celite
®
, which was eluted with EtOAc/EtOH (9:1, 12 mL) and the solvent was 
concentrated in vacuo. The residue was purified by flash chromatography (Florisil
®
, 
hexanes/EtOAc, 1:1  1:2) to yield the title compound as a white foam (8.1 mg, 84%). 
D
20][  = ‒66.4 (c = 0.94, CD2Cl2); 
1
H NMR (600 MHz, CD2Cl2): see Table S-2; 
13
C NMR 
(150 MHz, CD2Cl2): see Table S-2; IR (film):   = 3452, 3365, 2965, 2931, 1723, 1602, 
1455, 1376, 1312, 1259, 1209, 1146, 1092, 1058, 1033, 954, 916, 863, 801, 748, 710, 679 
cm
-1
; HRMS (ESIpos): m/z: calcd. for C36H55NO9Na [M
+
+Na]: 668.37800, found 
668.37740. 
When applied to 50.2 mg (83.3 µmol) of compound 40 this reaction yielded 40.5 mg 







C data of the semi-reduced 





H NMR (CD2Cl2, 600 MHz) 
13
C NMR (CD2Cl2, 150 MHz) 
Nr  (ppm) Integral Splitting COSY J (Hz)  (ppm) HMBC 
1 - - - - - 172.4 2, 15 
2a 2.31 - 2.36 1H m 2b, 3a - 
33.7 1, 3, 5, 26 
2b 1.91 - 1.96 1H m 2a, 3b - 
3 2.15 - 2.23 2H m 2a, 2b, 4 - 22.2 1, 2, 4, 26 
4 5.09 - 5.14 1H m 3a, 3b, 26 - 126.3 2, 3, 6, 26 
5 - - - - - 137.0 3, 6, 7, 26, 27 
6 2.54 - 2.63 1H m 7, 27 - 47.9 4, 5, 7, 26, 27 
7 3.35 1H d 6 10.6 89.3 6, 9, 27, 28, 30 
8 1.62 - 1.69 1H m 30 - 38.9 7, 9, 10, 30 
9 5.04 1H d 10 9.8 65.0 7, 8, 11, OH1, 30 
10 5.57 1H dd 9, 11 9.9, 10.8 132.2 8, 9, 12, OH1 
11 6.29 1H dd 10, 12 10.9, 11.4 124.3 9, 12, 13, 14 
12 6.45 1H dd 11, 13 10.7, 11.4 124.4 10, 13, 14, 31 
13 5.28 1H dd 12, 14 10.4, 10.7 136.3 11, 14, 15, 31 
14 2.98 - 3.03 1H m 13, 15, 31 - 35.1 12, 13, 15, 31 
15 5.09 1H d 14 10.4 82.9 13, 14, 16, 17, 31, 32 
16 - - - - - 133.8 14, 15, 17, 18 
17 6.09 1H d 18 10.9 129.7 15, 16, 18, 19, 32 
18 6.38 1H dd 17, 19 11.0, 15.0 131.4 17, 20, 32 
19 5.77 1H ddd 20a, 20b 7.5, 7.5, 15.0 128.5 17, 18, 20, 21 
20a 2.41 1H dd 19, 20b 14.0, 7.2 
38.5 18, 19, 21, 22, 34 
20b 2.16 - 2.22 1H m 19, 20a - 
21 - - - - - 72.0 19, 20a, 20b, 22, 34 
22 1.88 1H dq 23, 33 10.0, 6.9 43.2 20, 33, 34, 
23 3.91 1H ddd 22, 24a, 24b 10.0, 7.4, 2.8 83.8 22, 24, 25 
24a 1.83 1H ddq 23, 24b, 25 7.3, 7.4, 3.0 
27.1 23, 25 
24b 1.60 1H ddq 23, 24b, 25 7.3, 7.3, 7.4 
25 1.00 3H t 24a, 24b 7.3 9.2 24 
26 1.43 3H s 4 - 11.3 4, 5, 6 
27 1.09 3H d 6 6.8 16.4 5, 7, 30 
28a 4.72 1H d 28b 6.5 
99.8 7, 29 
28b 4.63 1H d 28a 6.5 
29 3.40 3H s - - 56.6 28 
30 1.06 3H d 8 7.3 12.0 5, 9 
31 0.86 3H d 14 6.7 16.6 13, 14, 15 
32 1.79 3H s 17 - 12.0 15, 17 
33 1.01 3H d 22 6.9 11.5 21, 22 
34a 2.72 1H d 34b 16.5 42.8 21, 35 
34b 2.34 1H d 34a 16.6   
35 - - - - - 170.3 34a, 34b 
OH1 2.91 1H br s     







C data of the allylic 




H (CD2Cl2, 600 MHz) 
13
C (CD2Cl2, 150 MHz) 
Nr  (ppm) Integral Splitting COSY J (Hz)  (ppm) HMBC 
1 - - - - - 172.3 2, 15 
2a 2.27 - 2.33 1H m 2b, 3a - 
33.8 1, 4, 5, 26 
2b 1.93 - 2.02 1H m 2a, 3b - 
3 2.18 - 2.23 2H m 2a, 2b, 4 - 22.3 1 
4 5.05 - 5.11 1H m 3a, 3b, 26 - 126.1 6 
5 - - - - - 137.3 3, 26, 27 
6 2.45 - 2.55 1H m 7, 27 - 48.2 6, 26, 27 
7 3.30 1H d 6 9.9 85.9 9, 27, 29 
8 1.72 - 1.79 1H br m 30 - 38.6 30 
9 5.92 1H br d 10 9.3 67.3 7, 11, 12, 30 
10 5.50 1H br dd 9, 11 9.3, 10.0 129.2 12 
11 6.32 1H br dd 10, 12 10.1, 11.1 125.1 9, 13, 15 
12 6.68 1H br dd 11, 13 10.7, 11.0 124.9 10, 14 
13 5.29 - 5.36 1H m 12, 14 - 136.8 11, 14, 15, 32 
14 2.95 - 3.03 1H m 13, 15, 32 - 34.9 12, 13, 15, 32 
15 5.08 1H d 14 10.3 82.7 13, 14, 16, 17, 32, 33 
16 - - - - - 133.9 14, 15, 17, 18, 19, 33 
17 6.10 1H d 18 10.9 129.8 15, 16, 17, 18, 19, 33 
18 6.39 1H dd 17, 19 10.9, 15.1 131.5 17, 20, 33 
19 5.77 1H ddd 18, 20a, 20b 7.6, 7.6, 15.1 128.3 17, 20, 21, 33 
20a 2.41 1H dd 19, 20b 14.0, 7.3 38.6 18, 19, 21, 22, 35 
20b 2.19 - 2.22 1H m 19, 20a -   
21 - - - - - 72.1 19, 20, 22, 34, 35 
22 1.89 1H dq 23, 34 9.9, 6.8 43.1 20, 34, 35 
23 3.91 1H ddd 22, 24a, 24b 10.1, 7.4, 2.9 83.8 22, 24, 25, 34 
24a 1.84 1H ddq 23, 24b, 25 7.4, 7.3, 2.8 
27.1 23, 25 
24b 1.62 1H ddq 23, 24b, 25 7.3, 7.3, 7.4 
25 1.00 3H t 24a, 24b 7.4 9.2 24 
26 1.43 3H br s - - 11.3 2, 6, 7 
27 1.08 3H d 6 6.6 16.7 5, 6, 7 
28a 4.70 1H d 28b 6.7 98.8 29 
28b 4.58 1H d 28a 6.7 - - 
29 3.38 3H s - - 56.2 28 
30 1.13 3H d 8 7.1 13.7 8, 27 
31 - - - - - 156.3 - 
32 0.86 3H d 14 6.6 16.6 13, 14, 15 
33 1.79 3H d 17 0.7 12.0 15, 16, 17, 19 
34 1.01 3H d 22 7.1 11.6 21, 22 
35a 2.73 1H d 34b 16.5 
42.8 21, 36 
35b 2.35 1H dd 34a 16.6, 0.3 
36 - - - - - 170.3 34a, 34b 
NH2 4.51 - 4.66 2H br s - - - - 
OH1 1.66 - 1.69 1H br s - - - - 
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Leiodermatolide (1). A solution of compound 41 (9.0 mg, 13.9 µmol) in CH2Cl2 
(1.6 mL) was cooled to ‒90 °C (Et2O/CO2/N2 
cooling bath) before a solution of freshly 
prepared Me2BBr (0.5 M in CH2Cl2, 30.6 µL, 
15.3 µmol)
12
 was carefully added via the 
cold wall of the flask. The reaction mixture 
was allowed to reach ‒78 °C and was stirred 
at this temperature for 1.5 h, when a second aliquot of Me2BBr (0.5 M, 30.6 µL, 
15.3 µmol) was introduced. After additional 1.5 h, the mixture was transferred via canula 
into a vigorously stirred mixture of sat. NaHCO3/H2O/THF (1:1:1, 10 mL) and the flask 
was rinsed with THF (2 x 0.7 mL). After stirring for 10 min, the mixture was diluted with 
EtOAc (10 mL), the aqueous layer was extracted with EtOAc (3 x 10 mL), the combined 
organic layers were dried over Na2SO4 and concentrated in vacuo. The residue was 
purified by preparative thin layer chromatography (TLC Silica gel 60 F254 (20 x 20 cm), 
hexanes/EtOAc, 2:5) to yield the title compound as a white solid (5.1 mg, 61%). D24][  = 
‒74.3 (c = 0.41, MeOH); 1H NMR (600 MHz, CD2Cl2, 4.8 mg in 0.3 mL CD2Cl2): δ = 
6.53 (dd, 1H, J = 11.7, 11.3 Hz), 6.39 (dd, 1H, J = 15.3, 10.7 Hz), 6.37 (dd, 1H, J = 
11.3, 11.2), 6.10 (d, 1H, J = 10.9 Hz), 5.89 (d, 1H, J = 10.1 Hz), 5.77 (ddd, 1H, J = 15.1, 
7.6, 7.6 Hz), 5.53 (dd, 1H, J = 10.4, 10.4 Hz), 5.35 (dd, 1H, J = 10.5, 10.4°Hz), 5.09 (m, 
1H), 5.07 (d, 1H, J = 10.3 Hz), 4.84 – 4.63 (br s, 2H), 3.91 (ddd, 1H, J = 10.1, 7.4, 
2.9 Hz), 3.26 (br t, 1H), 2.97 (ddq, 1H, J = 10.1, 10.1, 6.7 Hz), 2.73 (d, 1H, J = 16.5 Hz), 
2.46 (dq, 1H, J = 11.2, 5.8 Hz), 2.42 (dd, 1H, J = 14.0, 7.3 Hz), 2.35 (dd, 1H, J = 16.6, 
0.9 Hz), 2.31 (ddd, 1H, J = 16.7, 5.8, 3.0 Hz), 2.21 (dd, 1H, J = 13.9, 8.0 Hz), 2.27 – 
2.17 (m, 3H), 2.13 – 2.06 (br s, 1H), 1.99 (ddd, 1H, J = 16.7, 10.6, 3.6 Hz), 1.89 (dq, 1H, 
J = 10.3, 7.0 Hz), 1.83 (ddq, 1H, J = 7.4, 7.3, 3.1 Hz), 1.79 (d, 3H, J = 0.9 Hz), 1.74 (q, 
1H, J = 7.2 Hz), 1.62 (ddq, 1H, J = 14.7, 7.4, 7.3 Hz), 1.42 (s, 3H), 1.12 (d, 3H, J = 
6.7 Hz), 1.08 (d, 3H, J = 7.3 Hz), 1.02 (d, 3H, J = .6.8 Hz), 1.01 (t, 3H, J = 7.3 Hz), 0.86 
(d, 3H, J = 6.7 Hz); 
13
C NMR (150 MHz, CD2Cl2, 4.8 mg in 0.3 mL): δ = 172.2, 170.3, 
157.4, 137.6, 137.2, 133.8, 131.5, 129.8, 128.5, 128.4, 126.2, 125.6, 124.1, 83.8, 82.5, 
78.2, 72.1, 67.6, 48.5, 43.1, 42.8, 39.3, 38.6, 35.0, 33.7, 27.1, 22.2, 16.6, 16.5, 12.5, 12.0, 
11.6, 11.3, 9.2; IR (film):  = 3360, 2963, 2924, 1708, 1605, 1455, 1375, 1312, 1246, 
1207, 1148, 1082, 1056, 1040, 986, 949, 915, 778, 745 cm
-1
; MS (ESI) m/z (%): 624.4 
(100); HRMS (ESIpos): m/z: calcd. for C34H51NO8Na [M
+
+Na]: 624.35069, found 
624.35132. 
When applied to 40.5 mg (62.7 µmol) of compound 41 this reaction yielded 32.3 mg 







C data of leiodermatolide (1); 
numbering scheme as shown in the insert, data 





H (CD2Cl2, 600 MHz) 
13
C NMR (CD2Cl2, 150 MHz) 
Nr  (ppm) Integral Splitting COSY J (Hz)  (ppm) HMBC 
1 -- -- -- -- -- 172.2 2, 3, 15 
2a 2.31 1H ddd 2b, 3 16.7, n.d. 
33.7 3, 4, 26 
2b 1.99 1H ddd 2a, 3 16.7, n.d. 
3 2.20 2H m 2, 4, 26 -- 22.2 2, 4, 5, 26 
4 5.09 1H ddq 3, 26 9.9, 5.5, 1.6 125.6 2, 3, 5, 6, 26 
5 -- -- -- -- -- 137.2 3, 4, 6, 26, 27 
6 2.46 1H dq 7, 27 10.5, 6.7 48.5 4, 7, 25, 26, 27 
7 3.26 1H br t OH, 6, 8 9.9 78.2 6, 8, 9, 28 
8 1.74 1H qt 7, 27, 28 7.4, n.d. 39.3 7, 10, 28 
9 5.89 1H d 10 10.0 67.6 7, 28, 11 
10 5.53 1H ddt 9, 11 10.7, 10.0, 1.4 128.5 9, 11, 12, 13 
11 6.38 1H ddt 10, 12 12.0, 10.9 126.2 9, 10, 12, 13 
12 6.53 1H ddt 11, 13 11.8, 11.0, 1.0 124.4 10, 11, 13, 14 
13 5.35 1H ddt 12, 14 10.8, 10.2, 1.4 137.6 11, 12, 14, 15, 29 
14 2.98 1H tq 13, 15, 29 10.2, 6.7 35.0 12, 13, 15, 29, 30 
15 5.07 1H d 14 10.3 82.5 12, 13, 14, 17, 29, 30 
16 -- -- -- -- -- 133.8 14, 15, 17, 18, 30 
17 6.10 1H dq 18, 30 10.9, 1.4 129.7 15, 16, 18, 19, 30 
18 6.40 1H ddt 17,19, 20 15.1, 10.9, 1.3 131.5 16, 17, 20, 30 
19 5.76 1H dt 18, 20 15.0, 7.6 128.4 17, 20, 30 
20a 2.41 1H dd 19, 20b 14.0, 7.5 
38.6 18, 19, 32 
20b 2.22 1H dd 19, 20a 13.8, 7.9 
21      72.1 18, 19, 20, 22, 31, 32 
22 1.89 1H dq 23, 31 10.5, 6.7 43.1 20, 21, 23, 24, 31, 32 
23 3.91 1H ddd 22, 24 10.0, 7.6, 3.1 83.8 22, 24, 25, 31 
24a 1.85 1H ddq 23, 24b, 25 14.5, 7.4, 3.1 
27.1 22, 23, 25 
24b 1.62 1H dq 23, 24a, 25 14.6, 7.4 
25 1.01 3H t 24 7.3 9.2 23, 24 
26 1.42. 3H s 3, 4 - 11.3 3, 4, 5, 6 
27 1.12 3H d 6 6.7 16.5 5, 6 
28 1.08 3H d 8 7.3 12.5 7, 8, 9 
29 0.87 3H d 14 6.7 16.6 13, 14, 15 
30 1.79 3H d 17 1.0 12.0 14, 15, 16, 17, 18, 19 
31 1.02 3H d 22 6.8 11.6 21, 22, 23, 32 
32a 2.72 1H d 32b 16.4 
42.8 21, 22, 31, 33 
32b 2.35 1H dd 32a 16.5, 1.0 
33 -- -- -- -- -- 170.3 32 
34 -- -- -- -- -- 157.4 9 
NH2 4.66 2H br s -- -- -- -- 
C7-OH 2.16 1H d 7 7.9 -- -- 
C21-OH 1.91 1H s -- -- -- -- 
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 Completion of the Total Synthesis (Route B) 
Diyne 37. A solution of silyl ether 4 (60.0 mg, 85.9 µmol) in THF (0.6 mL) was cooled 
to 0 °C and a solution of TBAF (1.0 M in THF, 258 μL, 258 µmol) was added dropwise 
via syringe. The reaction mixture was allowed to warm to 
room temperature and was stirred for 3 h before being 
quenched with brine (5 mL). The aqueous layer was 
extracted with EtOAc (3 x 5 mL) and the combined 
organic layers were dried over Na2SO4 and concentrated 
in vacuo. The residue was purified by flash column 
chromatography (silica, hexanes/EtOAc, 6:1  5:1) to yield the title compound as a 
colorless viscous liquid (44.2 mg, 88% yield). D20][  = +97.0 (c = 1.15, CH2Cl2). 
1
H NMR 
(500 MHz, C6D6): δ = 6.22 (s, 1H), 5.54 – 4.46 (m, 2H), 5.29 (d, J = 7.6 Hz, 1H), 5.09 
(dd, J = 7.1 Hz, 6.7 Hz, 1H), 5.05 (br s, 1H), 4.36 (s, 2H), 3.54 (dd, J = 7.6, 4.0 Hz, 1H), 
3.33 (br s, 1H), 3.28 – 3.19 (m, 1H), 3.05 (s, 3H), 2.25 – 2.18 (m, 3H), 2.15 (dd, J = 7.8, 
6.7 Hz, 1H), 2.12 – 2.05 (m, 1H), 2.02 – 1.95 (m, 1H), 1.80 (s, 3H), 1.60 (d, J = 1.3 Hz, 
3H), 1.55 (d, J = 2.2 Hz, 3H), 1.23 (d, J = 6.9 Hz, 3H), 1.00 (d, J = 6.9 Hz, 3H), 0.79 (d, 
J = 6.8 Hz, 3H); 
13
C NMR (125 MHz, C6D6): δ = 171.6, 145.1, 142.6, 138.7, 124.0, 
111.5, 99.4, 90.8, 84.1, 81.5, 81.2, 80.3, 80.1, 76.7, 63.2, 56.2, 44.0, 42.3, 37.6, 34.3, 
23.8, 20.6, 16.8, 15.5, 13.1, 12.1, 4.2, 3.4; IR (film):  = 3480, 2967, 2918, 2864, 1736, 
1454, 1376, 1243, 1213, 1142, 1088, 1023, 980, 927, 757, 674 cm
-1
; MS (ESI) m/z (%): 
607.2 (100); HRMS (ESIpos): m/z: calcd. for C28H41O5I1Na [M
+
+Na]: 607.18909, found 
607.18933. 
Macrocycle 38. Care should be taken to exclude moisture during the ring closing alkyne 
metathesis step. A flame-dried Schlenck tube was charged 
with 5Å MS (1.2 g) and flame-dried until a stable vacuum 
was obtained. Toluene (45 mL) and a solution of diyne 37 
(45.0 mg, 77.0 µmol) in toluene (1.0 mL + 0.5 mL rinse) 
was added via syringe and the resulting suspension stirred 
for 30 min at room temperature. A solution of catalyst 10 (12.0 mg, 11.5 µmol) in toluene 
(1.2 mL) was added and the reaction mixture stirred for 13 h at room temperature. After 
complete conversion of starting material (HPLC: 50 mm Zorbax Eclipse Plus C18, 1.8 
µm, 3mm Ø, MeOH/H2O = 90:10, 0.5 mL/min 224 bar: Rt (product) = 1.09 min; Rt 
(starting material) = 1.49 min; Rt (dimer) = 3.57 min), the reaction mixture was filtered 
through a pad of Celite
®
, rinsed with Et2O (150 mL) and the filtrate concentrated in 
vacuo. The residue was purified by flash column chromatography (silica, 
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hexanes/EtOAc, 6:1  4:1) to yield the title compound as a light yellow viscous liquid 
(24.8 mg, 61% yield). D20][  = +86.7 (c = 0.83, CH2Cl2). 
1H NMR (400 MHz, ): δ = 6.16 
(dq, J = 1.2, 1.0 Hz, 1H), 5.64 (dd, J = 10.5, 8.5 Hz, 1H), 5.58 (dd, J = 10.7, 0.9 Hz), 
5.34 (td, J = 6.7, 1.0 Hz, 1H), 5.27 (d, J = 5.1 Hz, 1H), 4.97 (s, 1H), 4.71 (d, J = 6.7 Hz, 
1H), 4.66 (d, J = 6.7 Hz, 1H), 3.46 (dd, J = 9.4, 2.4 Hz, 1H), 3.42 (s, 3H), 3.27 (d, J = 
2.1 Hz, 1H), 2.56 (dq, J = 9.2, 6.9 Hz, 1H), 2.44 – 2.37 (m, 2H), 2.37 – 2.30 (m, 1H), 
2.28 – 2.22 (m, 1H), 1.91 (qt, J = 7.2, 2.5 Hz, 1H), 1.78 (d, J = 1.0 Hz, 3H), 1.54 (d, J = 
0.8 Hz, 3H), 1.19 (d, J = 7.2 Hz, 3H), 1.08 (d, J = 6.8 Hz, 3H), 0.94 (d, J = 6.9 Hz, 3H); 
13
C NMR (CDCl3, 100 MHz): δ = 171.7, 144.1, 138.2, 125.5, 111.3, 99.2, 96.1, 87.7, 
80.8, 79.8, 79.6, 63.2, 56.7, 46.7, 40.6, 38.7, 34.3, 22.7, 22.2, 17.0, 14.8, 13.3, 12.9; IR 
(film):  = 3481, 2962, 2928, 2869, 1737, 1456, 1378, 1261, 1185, 1146, 1091, 1025, 
929, 754 cm
-1
; MS (ESI) m/z (%): 553.1 (100); HRMS (ESIpos): m/z: calcd. for 
C24H35O5I1Na [M
+
+Na]: 553.14214, found 553.14202. 
Alternative synthesis of propargylic alcohol 39a. DMF used for the Stille-Migita cross 
coupling was degassed by Ar bubbling 
for 30 min prior to use. Tetra-n-
butylammonium diphenylphosphinate was 
melted and allowed to return to room 
temperature under high vacuum (10
−2
 
mbar) twice prior to use. A solution of vinyl iodide 38 (22.0 mg, 41.5 µmol) and vinyl 
stannane 35 (28.3 mg, 58.1 µmol) in DMF (1.2 mL) was added to a Schlenk tube 
containing flame-dried [(nBu4N)(Ph2PO2)] (28.6 mg, 62.3 µmol). Copper-thiophene 
carboxylate complex (CuTC, 12.7 mg, 66.4 µmol) was then introduced followed by 
Pd(PPh3)4 (2.4 mg, 2.1 µmol) inducing color changes of the reaction mixture from yellow 
to orange and dark brown respectively. The reaction mixture was then stirred at room 
temperature for 1 min before being quenched with H2O (1.5 mL). The aqueous layer was 
extracted with Et2O (5 x 4 mL), the combined organic layers were dried over Na2SO4 and 
concentrated in vacuo. The residue was purified by flash chromatography (Florisil
®
, 
hexanes:EtOAc, 3:1  3:2) to yield the title compound as a yellow solid (22.4 mg, 90%). 
The analytical data matched those of the compound obtained by Route A. 
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Synthesis of Leiodermatolide Analogues 
For the synthesis and spectra of compound 2 bearing the enantiomeric -lactone side 




 Analogue A (Compound 44)  
Vinyl stannane A0b. A solution of methyl 5-hexynoate A0a (63.1 mg, 500 µmol) in dry 
THF (1.0 mL) was added slowly to a suspension of freshly 
prepared dicyclohexylborane (128 mg, 750 µmol) in dry THF 
(1.0 mL) at 0 °C.
14
 The reaction mixture was stirred for 1 h at 
0 °C and then carefully treated with aq. NaOH (2 M, 375 μL, 750 µmol) at 0 °C, allowed 
to warm to room temperature and stirred for 30 min. The reaction mixture was cooled to 
–15 °C and Cu(acac)2 (6.6 mg, 25 µmol) and (nBu)3SnCl (179 mg, 550 µmol) were 
succesively added. The reaction mixture was warmed to room temperature over 5 h, 
poured into H2O (10 mL) and extracted with hexanes (4 × 10 mL). The combined organic 
layer were dried over Na2SO4 and concentrated in vacuo. The residue was purified by 
flash chromatography (silica, hexanes:EtOAc, 9:1  1:1) to yield the title compound as a 
colorless liquid (58.0 mg, 28%). 
1
H NMR (400 MHz, CDCl3): δ = 6.02 – 5.73 (m, 2H), 
3.64 (s, 3H), 2.33 – 2.25 (m, 2H), 2.19 – 2.08 (m, 2H), 1.75 – 1.67 (m, 2H), 1.53 – 1.38 
(m, 6H), 1.32 – 1.23 (m, 6H), 0.93 – 0.73 (m, 15H); 13C NMR (100 MHz, CDCl3): δ = 
174.4, 148.1, 128.8, 51.6, 37.2, 33.5, 29.2, 29.2, 29.2, 27.4, 27.4, 27.4, 24.2, 13.9, 13.9, 
13.9, 9.5, 9.5, 9.5; IR (film):  = 2954, 2924, 2871, 2852, 1742, 1599, 1456, 1436, 1247, 
1196, 1170, 1071, 988, 873, 689, 663, 631, 594, 505 cm
-1
; MS (ESI) m/z 376.2 [M
+
+Na]; 
HRMS (ESI): m/z: calcd. for C19H38O2SnNa [M
+
+Na]: 441.17853, found 441.17871. 
Silyl ether A1. DMF used for the Stille-Migita cross coupling was degassed by Ar 
bubbling for 30 min prior to use. Tetra-
n-butylammonium diphenylphosphinate 
was melted and allowed to return to 
room temperature under high vacuum 
(10
−2
 mbar) twice prior to use. A 
solution of vinyl iodide 3 (25.0 mg, 38.8 µmol) and vinyl stannane A0b (17.9 mg, 
42.7 µmol) in DMF (400 µL) was added to a Schlenk tube containing flame-dried 
[(nBu4N)(Ph2PO2)] (19.7 mg, 42.7 µmol). Copper-thiophene carboxylate complex 
(CuTC, 11.1 mg, 58.2 µmol) was then introduced followed by Pd(PPh3)4 (4.5 mg, 
3.9 µmol) inducing color changes of the reaction mixture from yellow to orange and dark 
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green respectively. The reaction mixture was then stirred at room temperature for 1 min 
before being quenched with H2O (1.0 mL). The aqueous layer was extracted with Et2O (5 
x 2 mL), the combined organic layers were dried over Na2SO4 and concentrated in vacuo. 
The residue was purified by flash chromatography (silica, hexanes:EtOAc, 9:1  17:3) 
to yield the title compound as a yellow viscous liquid (19.9 mg, 80%). D20][  = +100.8 (c 
= 1.00, CHCl3); 
1
H NMR (400 MHz, CDCl3): δ = 6.21 (dd, J = 15.2, 10.9 Hz, 1H), 5.99 
(dd, J = 11.0, 1.7 Hz, 1H), 5.66 (ddd, J = 15.0, 7.6, 7.6 Hz, 1H), 5.72 – 5.60 (m, 1H), 
5.52 (dd, J = 10.7, 1.7 Hz, 1H), 5.42 – 5.30 (m, 1H), 5.08 (d, J = 9.8 Hz, 1H), 4.73 (d, J 
= 6.8 Hz, 1H), 4.62 (d, J = 6.8 Hz, 1H), 4.36 (dd, J = 9.2, 1.8 Hz, 1H), 3.64 (s, 3H), 3.43 
(br d, J = 9.2 Hz, 1H), 3.39 (s, 3H), 3.19 (ddq, J = 9.8, 9.8, 6.6 Hz, 1H), 2.95 (br s, 1H), 
2.47 – 2.33 (m, 1H), 2.34 – 2.25 (m, 4H), 2.24 – 2.03 (m, 4H), 1.74 (s, 3H), 1.81 – 1.66 
(m, 2H), 1.46 (s, 3H), 1.08 (d, J = 7.1 Hz, 3H), 1.00 (d, J = 6.8 Hz, 3H), 0.89 (s, 9H), 
0.81 (d, J = 6.8 Hz, 3H), 0.11 (s, 3H), 0.07 (s, 3H); 
13
C NMR (100 MHz, CDCl3): δ = 
174.1, 172.3, 145.6, 137.2, 134.9, 132.1, 130.0, 127.0, 126.6, 109.8, 99.1, 96.6, 87.3, 
83.0, 82.5, 64.1, 56.2, 51.6, 46.2, 42.1, 37.9, 34.9, 33.6, 32.4, 25.9, 24.6, 22.7, 18.3, 17.6, 
16.8, 16.8, 12.1, 12.1, ‒4.3, ‒5.0; IR (film):  = 2953, 2930, 2857, 1737, 1436, 1362, 
1339, 1250, 1218, 1144, 1059, 1034, 986, 920, 859, 836, 776, 754 cm
-1
; HRMS (ESIpos): 
m/z: calcd. for C37H60NaO7Si [M
+
+Na]: 667.40005, found 667.39994. 
Propargylic alcohol A2. TBAF (1 M in THF, 21.3 µL, 21.3 µmol) was slowly added to a 
suspension of silyl ether A1 (5.5 mg, 
8.5 µmol) and activated 4Å molecular 
sieves (13.0 mg, powder) in THF 
(100 µL) at 0 °C. After 20 min, the 
reaction was quenched with H2O/brine 
(2:1, 1 mL) and diluted with EtOAc (1 mL). The aqueous layer was extracted with 
EtOAc (3 x 1 mL) and the combined organic layers were dried over Na2SO4 and 
concentrated in vacuo. The residue was quickly purified by flash chromatography 
(Florisil
®
, hexanes/EtOAc, 4:1  2:3), keeping the contact time with the Florisil® as 
short as possible. The yellow viscous liquid (3.4 mg, 76%) thus obtained was 
immediately used in the next step as it decomposes upon storage in a freezer. 
1
H NMR 
(400 MHz, C6D6): δ = 6.24 (ddt, J = 13.7, 10.8, 1.5 Hz, 1H), 6.13 – 6.03 (m, 1H), 5.58 – 
5.42 (m, 4H), 5.41 – 5.31 (m, 1H), 5.07 (br t, J = 3.3 Hz, 1H), 4.37 (s, 2H), 3.39 (dd, J = 
8.6, 3.0 Hz, 1H), 3.33 (s, 3H), 3.35 – 3.27 (m, 1H), 3.08 (s, 3H), 2.86 (d, J = 3.1 Hz, 1H), 
2.61 – 2.48 (m, 1H), 2.27 – 2.14 (m, 3H), 2.14 – 2.00 (m, 4H), 2.02 – 1.89 (m, 2H), 1.67 
(d, J = 1.3 Hz, 3H), 1.66 – 1.52 (m, 2H), 1.38 (d, J = 1.3 Hz, 3H), 1.31 (d, J = 7.1 Hz, 
S42 
 
3H), 0.98 (d, J = 6.9 Hz, 3H), 0.90 (d, J = 6.8 Hz, 3H); IR (film):  = 3483, 2931, 2299, 
1736, 1438, 1365, 1148, 1023, 758 cm
-1
; HRMS (ESIpos): m/z: calcd. for C31H46NaO7 
[M
+
+Na]: 553.31357, found 553.31357. 
When applied to 22.9 mg (35.5 µmol) of silyl ether A1 this reaction yielded 12.9 mg 
(69%) of propargylic alcohol A2. 
Allylic alcohol A3. A solution of propargyl alcohol A2 (17.3 mg, 31.8 µmol) in THF 
(200 µL) was added to a suspension of 
freshly prepared Zn(Cu/Ag) (590 mg) in 
degassed MeOH/H2O (1:1, 400 µL) and the 
resulting mixture was stirred at 50 °C for 
72 h. After cooling to room temperature, the 
mixture was diluted with EtOAc (2 mL) and filtered through a short pad of Celite
®
, 
which was carefully rinsed with EtOAc (50 mL) and EtOH (5 mL). The combined 
filtrates were concentrated in vacuo. The residue was purified by flash chromatography 
(Florisil
®
, hexanes/EtOAc, 4:1  1:1) to yield the title compound as a colorless viscous 
liquid (15.2 mg, 88%). D20][  = ‒7.8 (c = 1.00, CH2Cl2); 
1
H NMR (500 MHz, CDCl3): δ = 
6.41 (dd, J = 14.0, 8.6 Hz, 1H), 6.30 – 6.22 (m, 1H), 6.22 – 6.10 (m, 1H), 6.00 (d, J = 
10.7 Hz, 1H), 5.64 (dt, J = 14.6, 7.0 Hz, 1H), 5.60 – 5.48 (m, 1H), 5.33 – 5.19 (m, 1H), 
5.17 – 5.09 (m, 1H), 5.09 – 4.98 (m, 1H), 5.06 (d, J = 10.1 Hz, 1H), 4.70 (d, J = 6.5 Hz, 
1H), 4.62 (d, J = 6.5 Hz, 1H), 3.63 (s, 3H), 3.40 (s, 3H), 3.32 (d, J = 10.7 Hz, 1H), 2.98 – 
2.86 (m, 2H), 2.61 – 2.46 (m, 1H), 2.33 – 2.21 (m, 4H), 2.19 – 2.05 (m, 3H), 1.98 – 1.85 
(m, 1H), 1.73 (s, 3H), 1.72 – 1.58 (m, 3H), 1.39 (s, 3H), 1.07 (d, J = 7.2 Hz, 3H), 1.06 (d, 
J = 6.9 Hz, 3H), 0.83 (d, J = 6.4 Hz, 3H); 
13
C NMR (125 MHz, CDCl3): δ = 174.0, 
172.3, 136.5, 136.3, 135.0, 131.7, 131.6, 130.3, 126.5, 126.4, 124.4, 124.2, 99.6, 89.2, 
83.0, 64.9, 56.6, 51.6, 47.7, 38.8, 35.0, 33.6, 33.5, 32.3, 24.5, 22.0, 16.7, 16.4, 12.1, 11.9, 
11.3; IR (film):   = 3531, 2961, 2928, 1734, 1452, 1437, 1366, 1243, 1205, 1148, 1091, 
1021, 985, 968, 949, 917, 748 cm
-1
; HRMS (ESIpos): m/z: calcd. for C31H48NaO7 
[M
+
+Na]: 555.32922, found 555.32968. 
Allylic carbamate A4. A solution of trichloroacetyl isocyanate (0.5 M in CH2Cl2, 
45.0 µL, 22.5 µmol) was carefully added at 
‒78 °C along the cold wall of a precooled 
solution of the allylic alcohol A3 (6.0 mg, 
11.2 µmol) in CH2Cl2 (400 µL). The mixture 
was stirred at ‒78 °C for 0.5 h, before being 
quenched with MeOH (50 µL) at this 
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temperature. After warming and concentration in vacuo, the residue was dissolved in 
CH2Cl2 (1 mL) and the solution soaked on basic alumina. After 1.5 h, the alumina was 
loaded onto a short pad of Celite
®
, which was eluted with EtOAc/EtOH (9:1, 25 mL) and 
the solvent was concentrated in vacuo. The residue was purified by flash chromatography 
(Florisil
®
, hexanes/EtOAc, 3:2  1:2) to yield the title compound as a colorless viscous 
liquid (5.2 mg, 81%). D20][  = ‒57.4 (c = 1.00, CH2Cl2); 
1
H NMR (600 MHz, CD2Cl2): δ 
= 6.67 (dd, J = 11.5 Hz, 11.4 Hz, 1H), 6.35 – 6.29 (m, 1H), 6.26 (ddt, J = 15.1, 10.9, 1.3 
Hz, 1H), 6.03 (dd, J = 10.9, 1.6 Hz, 1H), 5.91 (d, J = 10.4 Hz, 1H), 5.70 (dt, J = 15.1, 
7.1 Hz, 1H), 5.49 (t, J = 11.0 Hz, 1H), 5.36 – 5.28 (m, 1H), 5.10 – 5.01 (m, 1H), 5.05 (d, 
J = 10.4 Hz, 1H), 4.70 (d, J = 6.8 Hz, 1H), 4.57 (d, J = 6.8 Hz, 1H), 4.51 (br s, 2H), 3.62 
(s, 3H), 3.37 (s, 3H), 3.29 (d, J = 10.7 Hz, 1H), 3.05 – 2.91 (m, 1H), 2.54 – 2.44 (m, 1H), 
2.34 – 2.27 (m, 3H), 2.24 – 2.16 (m, 2H), 2.16 – 2.10 (m, 2H), 2.02 – 1.91 (m, 1H), 1.79 
– 1.73 (m, 1H), 1.76 (s, 3H), 1.73 – 1.65 (m, 2H), 1.42 (s, 3H), 1.12 (d, J = 7.4 Hz, 3H), 
1.08 (d, J = 6.7 Hz, 3H), 0.84 (d, J = 6.6 Hz, 3H); 
13
C NMR (150 MHz, CD2Cl2): δ = 
174.0, 172.2, 156.2, 137.1, 136.9, 135.4, 131.8, 130.4, 128.9, 126.5, 126.0, 125.0, 124.6, 
98.7, 85.8, 82.8, 67.1, 56.1, 51.6, 48.1, 38.4, 34.7, 33.6, 33.5, 32.4, 24.6, 22.2, 16.6, 16.5, 
13.6, 11.7, 11.3; IR (film):  = 3374, 2956, 2924, 2854, 1729, 1676, 1602, 1455, 1437, 
1367, 1312, 1260, 1204, 1146, 1092, 1057, 1027, 915, 801, 745, 701 cm
-1
; HRMS 
(ESIpos): m/z: calcd. for C32H49NNaO8 [M
+
+Na]: 598.335037, found 598.33537.  
When applied to 9.2 mg (17.3 µmol) of allylic alcohol A3 this reaction yielded 7.6 mg 
(77%) of allylic carbamate A4. 
Analogue 43. A solution of allylic carbamate A4 (1.5 mg, 2.60 µmol) in CH2Cl2 (260 
µL) was cooled to ‒90 °C (Et2O/CO2/N2 cooling 
bath) before a solution of freshly prepared Me2BBr 
(0.5 M in CH2Cl2, 6.4 µL, 3.20 µmol) was carefully 
added via the cold wall of the flask. The reaction 
mixture was allowed to reach ‒78 °C and was stirred 
at this temperature for 1 h, when a second aliquot of Me2BBr (0.5 M in CH2Cl2, 6.4 µL, 
3.20 µmol) was introduced. After additional 0.5 h, the mixture was transferred via canula 
into a vigorously stirred mixture of sat. NaHCO3/H2O/THF (1:1:1, 3 mL) and the flask 
was rinsed with THF (2 x 200 µL). After stirring for 0.5 h, the mixture was diluted with 
EtOAc (3 mL), the aqueous layer was extracted with EtOAc (3 x 3 mL), the combined 
organic layers were dried over Na2SO4 and concentrated in vacuo. The residue was 
purified by preparative thin layer chromatography (TLC Silica gel 60 F254 (20 x 20 cm), 
MeOH/CH2Cl2, 7:93) to yield the title compound as a colorless viscous liquid (1.0 mg, 
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67%, ~90% purity). 
1
H NMR (600 MHz, CD2Cl2): see Table S-4; 
13
C NMR (150 MHz, 
CD2Cl2): see Table S-4; IR (film):   = 3356, 2952, 2923, 2854, 1731, 1666, 1607, 1456, 
1435, 1375, 1316, 1259, 1203, 1149, 1082, 1056, 1026, 988, 965, 892, 797, 745, 699 cm
-
1
; HRMS (ESIpos): m/z: calcd. for C30H45NNaO7 [M
+
+Na]: 554.30882, found 
554.30886. When applied to 3.1 mg (5.38 µmol) of allylic carbamate A4 this reaction 






C data of leiodermatolide analogue 44; numbering scheme as shown 




H (CD2Cl2, 600 MHz) 
13
C NMR (CD2Cl2, 150 MHz) 
Nr  (ppm) Integral Splitting COSY J (Hz)  (ppm) HMBC 
1      172.2 2, 3, 15 
2a 2.29 1H m 2b, 3  
33.8 3 
2b 1.99 1H m 2a, 3  
3 2.20 2H m 2, 4, 26  22.3 2, 4 
4 5.10 1H m 3, 26  125.7 2, 3, 6 
5      137.3 3, 24, 25 
6 2.46 1H dq 7, 25 10.4, 6.7 48.6 4, 24, 25 
7 3.26 1H br t OH, 6, 8 9 78.2 6, 8, 9, 25, 26 
8 1.74 1H m 7, 28  39.4 26 
9 5.90 1H d 10 10.1 67.8 11, 26 
10 5.52 1H t 9, 11 10.4 128.5 8, 9, 11, 12 
11 6.37 1H t 10, 12 11.3 126.3 9, 12, 13 
12 6.52 1H t 11, 13 11.4 124.4 10, 11, 14 
13 5.35 1H m 12, 14  137.9 11, 14, 15, 28 
14 2.97 1H tq 13, 15, 28 10.3, 6.7 35.1 12, 13, 15, 28 
15 5.05 1H d 14 10.3 82.8 12, 13, 14, 16, 17, 28 
16      131.9 14, 15, 18, 29 
17 6.04 1H d 18, 29 10.9, n.d. 130.6 15, 18, 19, 29 
18 6.27 1H ddt 17,19, 20 15.1, 10.8, 1.4 126.7 17, 20, 29 
19 5.71 1H dt 18, 20 15.1, 7.1 135.5 17, 20, 21, 29 
20 2.15 2H q 18, 19, 21 7.4 32.6 18, 19, 21, 22 
21 1.71 2H qi 20, 22 7.6 24.8 19, 20, 22 
22 2.30 2H t 21 7.5 33.7 20, 21 
23      174.3 21, 22, 24 
24 1.42 3H s 3, 4  11.3 4, 6 
25 1.12 3H d 6 6.7 16.3 25 
26 1.08. 3H d 8 7.3 12.5 8, 9 
27      157.3 9 
28 0.86 3H d 14 6.7 16.6 13, 14, 15 
29 1.77 3H d 17 1.0 11.9 15, 17 
30 3.62 3H s   51.6  
NH2 4.65 2H br s     
C7-OH 2.14 1H d 7 n.d.   
S45 
 
 Analogue B  
Vinyl boronate B0b. A flame-dried Schlenk flask was charged with the Grubbs-II 
catalyst (42.5 mg, 50 µmol) and vinylB(MIDA) (96.1 mg, 
525 µmol), evacuated and backfilled with Ar (3 cycles). A 
solution of the homoallylic alcohol B0a (70.2 mg, 500 µmol) 
in CH2Cl2 (5.0 mL) was then introduced and the flask fitted 
with a reflux condenser and an Ar bubbler, allowing the generated ethylene to evaporate. 
The reaction mixture was heated to 40 °C for 22 h. After cooling to room temperature, 
DMSO (300 µL) was added and the mixture stirred for 8 h. The reaction mixture was 
then concentrated in vacuo and the residue was purified by flash chromatography (silica, 
MeCN/MTBE, 1:9  1:1) to yield the title compound as a white solid (102 mg, 69%). 1H 
NMR (400 MHz, DMSO-d6): δ = 6.05 (dt, J = 17.6, 7.0 Hz, 1H), 5.37 (d, J = 17.6 Hz, 
1H), 4.17 (d, J = 17.1 Hz, 2H), 3.95 (br s, 1H), 3.95 (d, J = 17.1 Hz, 2H), 2.74 (s, 3H), 
2.17 (dd, J = 7.0, 1.4 Hz, 2H), 1.63 – 1.49 (m, 2H), 1.45 – 1.14 (m, 8H); 13C NMR (100 
MHz, , DMSO-d6): δ = 169.1, 169.1, 140.7, 128.7, 69.6, 61.2, 61.2, 48.8, 46.7, 37.0, 
37.0, 25.5, 21.7, 21.7; IR (film):  = 3499, 3008, 2931, 2857, 1760, 1642, 1453, 1339, 
1292, 1259, 1195, 1151, 1123, 1090, 1022, 999, 961, 892, 863, 753 cm
-1
; HRMS (ESI): 
m/z: calcd. for C14H22BNO5Na [M
+
+Na]: 318.14832, found 318.14834. 
Silyl ether B1. THF/H2O used for the Suzuki-Miyaura cross coupling was degassed by 3 
freeze-pump-thaw cycles prior to use. A 
solution of vinyl iodide 3 (21.0 mg, 
32.5 µmol) in THF/H2O (3:1, 325 µL) was 
added to a degassed solution of MIDA ester 
B0b (11.6 mg, 11.6 µmol) and Pd(PPh3)4 
(7.6 mg, 6.5 µmol). Thallium ethoxide (13.9 µL, 196 µmol) was added via syringe to the 
resulting yellow mixture, which was stirred at room temperature for 1.5 h before being 
diluted with MTBE (3 mL) and transferred to a round-bottom flask fitted with a stirbar. 
Aqueous HCl (0.5 M, 3 mL) was introduced (pH ~ 2) and the mixture stirred for 1 h. H2O 
(12 mL) was added and the aqueous layer was extracted with tert-butyl methyl ether (5 x 
12 mL). The combined organic layers were washed with brine (12 mL), dried over 
Na2SO4 and concentrated in vacuo. The residue was purified by flash chromatography 
(silica, hexanes/EtOAc, 1:0  3:2) to yield the title compound as a yellow viscous liquid 
(13.2 mg, 62%). D20][  = +119.3 (c = 0.40, CHCl3); 
1
H NMR (600 MHz, CDCl3): δ = 6.27 
(ddt, J = 15.1, 10.9, 1.2 Hz, 1H), 6.03 (dd, J = 10.8, 1.6 Hz, 1H), 5.76 (dt, J = 15.2, 7.7 
Hz, 1H), 5.67 (t, J = 10.4 Hz, 1H), 5.53 (dd, J = 10.7, 1.7 Hz, 1H), 5.42 – 5.34 (m, 1H), 
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5.09 (d, J = 9.8 Hz, 1H), 4.73 (d, J = 6.8 Hz, 1H), 4.63 (d, J = 6.9 Hz, 1H), 4.36 (dd, J = 
9.2, 1.7 Hz, 1H), 3.43 (br s, 1H), 3.39 (s, 3H), 3.20 (ddq, J = 9.9, 9.8, 6.8 Hz, 1H), 2.96 
(br s, 1H), 2.41 (dd, J = 13.9, 7.5 Hz, 1H), 2.33 – 2.26 (m, 2H), 2.26 – 2.22 (m, 2H), 2.21 
– 2.16 (m, 1H), 2.10 (ddq, J = 8.4, 7.0, 1.4 Hz, 1H), 1.75 (d, J = 1.3 Hz, 3H), 1.64 – 1.44 
(m, 8H), 1.46 (s, 3H), 1.44 – 1.37 (m, 2H), 1.35 (br s, 1H), 1.08 (d, J = 7.1 Hz, 3H), 1.00 
(d, J = 6.8 Hz, 3H), 0.89 (s, 9H), 0.82 (d, J = 6.9 Hz, 3H), 0.11 (s, 3H), 0.07 (s, 3H); 
13
C 
NMR (150 MHz, CDCl3): δ = 172.4, 145.5, 137.2, 132.6, 130.7, 129.8, 129.5, 127.0, 
109.9, 99.1, 96.6, 87.4, 83.0, 82.5, 71.6, 64.1, 56.2, 46.2, 46.1, 42.1, 37.9, 37.6, 37.6, 
34.9, 25.9, 25.9, 25.9, 25.9, 22.7, 22.3, 22.3, 18.4, 17.6, 17.0, 16.8, 12.2, 12.1, ‒4.3, ‒5.0; 
IR (film):  = 2927, 2857, 1730, 1454, 1251, 1145, 1062, 1034, 969, 860, 836, 775 cm-1; 
HRMS (ESIpos): m/z: calcd. for C39H64O6SiNa [M
+
+Na]: 679.43644, found 679.43659.  
Propargylic alcohol B2. TBAF (1 M in THF, 80.0 µL, 80.0 µmol) was slowly added to a 
suspension of silyl ether B1 (21.0 mg, 
32.0 µmol) and activated 4Å molecular sieves 
(60.0 mg, powder) in THF (100 µL) at 0 °C. 
After 20 min, the reaction was quenched with 
H2O/brine (2:1, 5 mL) and diluted with EtOAc 
(5 mL). The aqueous layer was extracted with EtOAc (3 x 5 mL) and the combined 
organic layers were dried over Na2SO4 and concentrated in vacuo. The residue was 
quickly purified by flash chromatography (Florisil
®
, hexanes/EtOAc, 4:1  2:3), keeping 
the contact time with the Florisil
®
 as short as possible. The yellow viscous liquid 
(15.0 mg) thus obtained was immediately used in the next step as it decomposes upon 
storage in a freezer. 
1
H NMR (400 MHz, C6D6): δ = 6.33 (ddt, J = 15.0, 10.9, 1.3 Hz, 
1H), 6.18 (d, J = 10.9, 1H), 5.75 (dt, J = 15.0, 7.6 Hz, 1H), 5.58 – 5.41 (m, 3H), 5.41 – 
5.33 (m, 1H), 5.07 (br t, J = 3.1 Hz, 1H), 4.38 (s, 2H), 3.39 (dd, J = 8.6, 3.0 Hz, 1H), 
3.35 – 3.24 (m, 1H), 3.09 (s, 3H), 2.88 (d, J = 3.1 Hz, 1H), 2.62 – 2.46 (m, 1H), 2.29 – 
2.16 (m, 3H), 2.16 – 2.04 (m, 3H), 2.04 – 1.96 (m, 1H), 1.71 (s, 3H), 1.63 – 1.51 (m, 2H), 
1.50 – 1.25 (m, 5H), 1.39 (s, 3H), 1.31 (d, J = 7.1 Hz, 3H), 1.25 – 1.14 (m, 3H), 1.13 – 
1.02 (m, 1H), 0.99 (d, J = 6.9 Hz, 3H), 0.91 (d, J = 6.8 Hz, 3H); IR (film):  = 2929, 
2849, 1727, 1448, 1379, 1266, 1145, 1029, 971 cm
-1
; HRMS (ESIpos): m/z: calcd. for 
C33H50O6Na [M
+
+Na]: 565.34996, found 565.34942. 
Allylic alcohol B3. A solution of propargyl 
alcohol B2 (15.0 mg, 27.6 µmol) in THF 
(200 µL) was added to a suspension of freshly 
prepared Zn(Cu/Ag) (610 mg) in degassed 
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MeOH/H2O (1:1, 400 µL) and the resulting mixture was stirred at 50 °C for 72 h. After 
cooling to room temperature, the mixture was diluted with EtOAc (2 mL) and filtered 
through a short pad of Celite
®
, which was carefully rinsed with EtOAc (100 mL) and 
EtOH (5 mL). The combined filtrates were concentrated in vacuo. The residue was 
purified by flash chromatography (Florisil
®
, hexanes/EtOAc, 4:1  1:1) to yield the title 
compound as a colorless viscous liquid (12.7 mg, 74% over two steps). D20][  = ‒6.6 (c = 
1.00, CH2Cl2); 
1
H NMR (400 MHz, CDCl3): δ = 6.43 (dd, J = 11.3, 11.2 Hz, 1H), 6.35 – 
6.19 (m, 2H), 6.05 (dd, J = 10.8, 1.7 Hz, 1H), 5.77 (dt, J = 15.2, 7.7 Hz, 1H), 5.58 (dd, J 
= 10.4, 10.3 Hz, 1H), 5.28 (dd, J = 11.5, 9.7 Hz, 1H), 5.20 – 5.10 (m, 1H), 5.10 – 5.00 
(m, 2H), 4.71 (d, J = 6.6 Hz, 1H), 4.63 (d, J = 6.6 Hz, 1H), 3.41 (s, 3H), 3.33 (d, J = 10.6 
Hz, 1H), 3.07 – 2.83 (m, 2H), 2.65 – 2.49 (m, 1H), 2.38 – 2.10 (m, 5H), 1.99 – 1.84 (m, 
1H), 1.76 (s, 3H), 1.66 – 1.55 (m, 3H), 1.54 – 1.43 (m, 6H), 1.43 – 1.34 (m, 3H), 1.41 (s, 
3H), 1.08 (d, J = 7.3 Hz, 3H), 1.07 (d, J = 6.8 Hz, 3H), 0.85 (d, J = 6.6 Hz, 3H); 
13
C 
NMR (125 MHz, CDCl3): δ = 172.4, 136.5, 136.2, 132.1, 131.7, 130.9, 130.3, 129.4, 
126.4, 124.5, 124.2, 99.6, 89.3, 83.0, 71.5, 64.9, 56.6, 47.7, 46.1, 38.8, 37.6, 37.6, 35.0, 
33.6, 25.9, 22.3, 22.3, 22.1, 16.7, 16.4, 12.2, 12.0, 11.4; IR (film):   = 3509, 2930, 2861, 
1732, 1452, 1413, 1367, 1246, 1207, 1148, 1090, 1068, 1022, 970, 947, 913, 748 cm
-1
; 
HRMS (ESIpos): m/z: calcd. for C33H52O6Na [M
+
+Na]: 567.36561, found 567.36600. 
Allylic carbamate B4. A solution of trichloroacetyl isocyanate (0.1 M in CH2Cl2, 
92.7 µL, 9.27 µmol) was carefully added at 
‒78 °C along the cold wall of a precooled 
solution of the allylic alcohol B3 (10.1 mg, 
18.5 µmol) in CH2Cl2 (1.0 mL). The reaction 
mixture was allowed to reach ‒78 °C and was 
stirred at this temperature for 20 min, when a 
second aliquot of trichloroacetyl isocyanate (0.1 M in CH2Cl2, 46.4 µL, 4.6 µmol) was 
introduced. After additional 20 min, a third aliquot of trichloroacetyl isocyanate (0.1 M in 
CH2Cl2, 46.4 µL, 4.6 µmol) was introduced the mixture was stirred at ‒78 °C for 20 min, 
before being quenched with MeOH (100 µL) at this temperature. After warming and 
concentration in vacuo, the residue was dissolved in CH2Cl2 (1 mL) and the solution 
soaked on basic alumina. After 1 h, the alumina was loaded onto a short pad of Celite
®
, 
which was eluted with EtOAc/EtOH (9:1, 50 mL) and the solvent was concentrated in 
vacuo. The residue was purified by flash chromatography (Florisil
®
, hexanes/EtOAc, 1:1 
 1:2) to yield the desired mono-carbamate B4 as a colorless viscous liquid (1.8 mg, 




H NMR (600 MHz, CD2Cl2): δ = 6.67 (dd, J = 11.5, 11.4 Hz, 1H), 6.36 – 6.26 (m, 2H), 
6.07 (dd, J = 10.9, 1.1 Hz, 1H), 5.91 (d, J = 10.4 Hz, 1H), 5.80 (dt, J = 15.2, 7.7 Hz, 
1H), 5.49 (t, J = 10.5 Hz, 1H), 5.34 – 5.30 (m, 1H), 5.10 – 5.04 (m, 1H), 5.06 (d, J = 
10.3 Hz, 1H), 4.70 (d, J = 6.8 Hz, 1H), 4.57 (d, J = 6.8 Hz, 1H), 4.50 (br s, 2H), 3.37 (s, 
3H), 3.29 (d, J = 10.6 Hz, 1H), 3.04 – 2.92 (m, 1H), 2.53 – 2.44 (m, 1H), 2.36 – 2.26 (m, 
1H), 2.26 – 2.22 (m, 2H), 2.21 – 2.13 (m, 3H), 2.04 – 1.89 (m, 2H), 1.77 (d, J = 1.0 Hz, 
3H), 1.78 – 1.72 (m, 1H), 1.63 – 1.54 (m, 2H), 1.53 – 1.43 (m, 3H), 1.42 (s, 3H), 1.40 – 
1.35 (m, 2H), 1.32 – 1.25 (m, 2H), 1.12 (d, J = 6.5 Hz, 3H), 1.08 (d, J = 6.7 Hz, 3H), 
0.85 (d, J = 6.6 Hz, 3H); 
13
C NMR (150 MHz, CD2Cl2): δ = 172.2, 156.1, 137.2, 136.8, 
132.2, 131.2, 130.3, 129.3, 129.0, 126.0, 125.0, 124.6, 98.7, 85.8, 82.8, 71.4, 67.1, 56.1, 
48.1, 38.4, 38.4, 37.6, 37.6, 34.7, 33.6, 26.0, 22.4, 22.4, 22.2, 16.6, 16.6, 13.6, 11.8, 11.3; 
HRMS (ESIpos): m/z: calcd. for C34H53NO7Na [M
+
+Na]: 610.37142, found 610.37192. 
Analogue 44. A solution of allylic carbamate B4 (1.4 mg, 2.38 µmol) in CH2Cl2 
(250 µL) was cooled to ‒90 °C (Et2O/CO2/N2 
cooling bath) before a solution of freshly 
prepared Me2BBr (0.1 M in CH2Cl2, 28.6 µL, 
2.86 µmol) was carefully added via the cold wall 
of the flask. The reaction mixture was allowed to 
reach ‒78 °C and was stirred at this temperature 
for 0.5 h, when a second aliquot of Me2BBr (0.1 M in CH2Cl2, 28.6 µL, 2.86 µmol) was 
introduced. After additional 0.5 h, the mixture was transferred via canula into a 
vigorously stirred mixture of sat. NaHCO3/H2O/THF (1:1:1, 3 mL) and the flask was 
rinsed with THF (2 x 200 µL). After stirring for 0.5 h, the mixture was diluted with 
EtOAc (3 mL), the aqueous layer was extracted with EtOAc (3 x 3 mL), the combined 
organic layers were dried over Na2SO4 and concentrated in vacuo. The residue was 
purified by preparative thin layer chromatography (TLC Silica gel 60 F254 (20 x 20 cm), 
MeOH/CH2Cl2, 7:93) to yield the title compound as a colorless viscous liquid (0.84 mg, 
65%). 
1
H NMR (600 MHz, CD2Cl2): δ = 6.53 (dd, J = 11.5, 11.4 Hz, 1H), 6.38 (dd, J = 
11.6, 11.0 Hz, 1H), 6.31 (ddt, J = 15.0, 10.9, 1.2 Hz, 1H), 6.08 (dd, J = 10.9, 1.1 Hz, 
1H), 5.90 (d, J = 10.1 Hz, 1H), 5.81 (dt, J = 15.3, 7.7 Hz, 1H), 5.53 (t, J = 10.4 Hz, 1H), 
5.39 – 5.33 (m, 1H), 5.12 – 5.08 (m, 1H), 5.06 (d, J = 10.3 Hz, 1H), 4.64 (br s, 2H), 3.26 
(br t, J = 9.5 Hz, 1H), 3.03 – 2.93 (m, 1H), 2.46 (dq, J = 13.2, 6.6 Hz, 1H), 2.32 – 2.27 
(m, 1H), 2.27 – 2.24 (m, 2H), 2.24 – 2.10 (m, 3H), 2.04 – 1.96 (m, 2H), 1.78 (d, J = 1.1 
Hz, 3H), 1.74 (dd, J = 14.6, 7.3 Hz, 1H), 1.62 – 1.54 (m, 3H), 1.51 – 1.44 (m, 3H), 1.42 
(s, 3H), 1.41 – 1.38 (m, 2H), 1.36 – 1.30 (m, 2H), 1.13 (d, J = 6.7 Hz, 3H), 1.09 (d, J = 
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7.3 Hz, 3H), 0.87 (d, J = 6.7 Hz, 3H); HRMS (ESIpos): m/z: calcd. for C32H49NO6Na 
[M
+
+Na]: 566.34521, found 566.34571. 
Analogue C5. A solution of bis-carbamate C4 (1.7 mg, 2.69 µmol) in CH2Cl2 (300 µL) 
was cooled to ‒90 °C (Et2O/CO2/N2 cooling bath) 
before a solution of freshly prepared Me2BBr 
(0.5 M in CH2Cl2, 10.8 µL, 5.39 µmol) was 
carefully added via the cold wall of the flask. The 
reaction mixture was allowed to reach ‒78 °C and 
was stirred at this temperature for 1 h, when a 
second aliquot of Me2BBr (0.5 M in CH2Cl2, 21.6 µL, 10.8 µmol) was introduced. After 
additional 1 h, the mixture was transferred via canula into a vigorously stirred mixture of 
sat. NaHCO3/H2O/THF (1:1:1, 3 mL) and the flask was rinsed with THF (2 x 200 µL). 
After stirring for 1 h, the mixture was diluted with EtOAc (3 mL), the aqueous layer was 
extracted with EtOAc (3 x 3 mL), the combined organic layers were dried over Na2SO4 
and concentrated in vacuo. The residue was purified by preparative thin layer 
chromatography (TLC Silica gel 60 F254 (20 x 20 cm), MeOH/CH2Cl2, 7:93) to yield the 
title compound as a colorless viscous liquid (1.26 mg, 80%). 
1
H NMR (600 MHz, 
CD2Cl2): δ = 6.53 (dd, J = 11.4, 11.3 Hz, 1H), 6.38 (dd, J = 11.3, 11.2 Hz, 1H), 6.30 
(ddt, J = 15.0, 10.9, 1.4 Hz, 1H), 6.06 (dd, J = 10.8, 1.2 Hz, 1H), 5.90 (d, J = 10.1 Hz, 
1H), 5.73 (dt, J = 15.1, 7.6 Hz, 1H), 5.56 – 5.50 (m, 1H), 5.38 – 5.34 (m, 1H), 5.12 – 
5.07 (m, 1H), 5.06 (d, J = 10.3 Hz, 1H), 4.65 (br s, 2H), 4.47 (br s, 2H), 3.26 (br t, J = 
9.4 Hz, 1H), 2.98 (dq, J = 10.2, 6.5 Hz, 1H), 2.76 – 2.65 (m, 2H), 2.50 – 2.42 (m, 1H), 
2.33 – 2.26 (m, 1H), 2.23 – 2.18 (m, 2H), 2.17 – 2.10 (m, 3H), 2.04 – 1.96 (m, 1H), 1.77 
(s, 3H), 1.74 (q, J = 7.2 Hz, 1H), 1.62 – 1.54 (m, 2H), 1.52 – 1.48 (m, 2H), 1.42 (s, 3H), 
1.40 – 1.33 (m, 2H), 1.33 – 1.23 (m, 2H), 1.13 (d, J = 6.7 Hz, 3H), 1.08 (d, J = 7.3 Hz, 
3H), 0.87 (d, J = 6.6 Hz, 3H); HRMS (ESIpos): m/z: calcd. for C33H50N2O7Na [M
+
+Na]: 
609.35102, found 609.35105. 
 
 Analogue D 
TMS-ether D0. Imidazole (57.7 mg, 847 µmol) and DMAP (17.3 mg, 142 µmol) were 
successively added to a solution of homoallylic alcohol 8 (56.0 mg, 
283 µmol) in CH2Cl2 (15 mL) at 0 °C. After stirring for 10 min at this 
temperature, TMSCl (72 µL, 566 µmol) was added to the reaction 
mixture. After stirring for 0.5 h at this temperature, the reaction 
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mixture was warmed to room temperature and stirred for additional 14 h. Then, the 
reaction was quenched with sat. aq. NaHCO3 (5 mL) and H2O (5 mL), the aqueous layer 
was extracted with Et2O (4 x 10 mL), the combined organic layers were dried over 
Na2SO4 and concentrated in vacuo. The residue was purified by flash chromatography 
(silica, hexanes/EtOAc, 19:1  17:3) to yield the title compound as a colorless viscous 
liquid (57.6 mg, 76%). D20][  = +35.2 (c = 1.00, CHCl3); 
1
H NMR (400 MHz, CDCl3): δ 
= 5.79 (dddd, J = 17.8, 10.3, 8.1, 5.8 Hz, 1H), 5.11 (d, J = 10.2 Hz, 1H), 5.05 (d, J = 
17.1 Hz, 1H), 3.90 (ddd, J = 10.3, 7.2, 3.0 Hz, 1H), 2.84 (d, J = 16.4 Hz, 1H), 2.39 (d, J 
= 16.6 Hz, 1H), 2.38 – 2.28 (m, 1H), 1.99 (dd, J = 13.9, 8.3 Hz, 1H), 1.91 – 1.73 (m, 
2H), 1.62 – 1.46 (m, 1H), 1.06 – 0.92 (m, 6H), 0.10 (s, 9H); 13C NMR (100 MHz, 
CDCl3): δ = 170.1, 133.0, 119.2, 83.8, 74.8, 43.9, 43.4, 39.9, 27.0, 11.1, 9.0, 2.5; IR 
(film):  = 2962, 1741, 1639, 1462, 1435, 1376, 1325, 1308, 1250, 1216, 1139, 1100, 
1079, 1008, 996, 941, 879, 840, 755, 667 cm
-1
; HRMS (EI): m/z: calcd. for C14H26O3SiNa 
[M
+
+Na]: 293.15435, found 293.15411. 
Disilyl ether D1. THF used for the B-alkyl Suzuki-Miyaura cross coupling was degassed 
by Ar bubbling for 30 min prior to use. A 
solution of 9-BBN dimer (3.7 mg, 
15.0 μmol) in THF (0.5 mL) was added 
dropwise via syringe to a solution of 
allylic -lactone D0 (3.0 mg, 11.0 μmol) 
in THF (0.5 mL) and the reaction mixture was stirred at 50 °C for 1 h. The solution of the 
resulting alkylborane was cooled to 0 °C, KOMe (2.1 mg, 30.0 µmol) was added in one 
portion and the reaction mixture was stirred at room temperature for 2 h. The resulting 
borate-solution was transferred dropwise via syringe to a solution of vinyl iodide 3 
(6.5 mg, 10.0 μmol), Pd(dppf)Cl2•CH2Cl2 (1.7 mg, 2.0 μmol) and AsPh3 (1.6 mg, 
5.0 μmol) in THF (0.5 mL).15 THF (0.5 mL) was used to rinse the vessel and the reaction 
mixture was stirred at 70 °C for 2 h. The reaction was quenched with sat. aq. NH4Cl 
(5 mL) and diluted with EtOAc (3 mL). The aqueous layer was then extracted with 
EtOAc (3 x 5 mL) and the combined organic layers were dried over Na2SO4 and 
concentrated in vacuo. The residue was purified by flash column chromatography (silica, 
hexanes/MTBE, 1:0  7:3) to yield a mixture of the title compound and the 
corresponding rather unstable γ-lactol as a yellow viscous liquid (4.1 mg). Then, PCC 
(4.5 mg, 20.8 µmol) was added to a solution of this mixture in CH2Cl2 (5.0 mL) and the 
reaction mixture was stirred at room temperature for 2 h. The resulting dark brown 
suspension was then filtered through a short pad of SiO2, washed with MTBE (25 mL) 
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and concentrated in vacuo. The residue was purified by flash chromatography (silica, 
hexanes/EtOAc, 9:1  4:1) to yield the title compound as a colorless viscous liquid 
(2.0 mg, 47% over two steps). D20][  = +68.3 (c = 1.00, CHCl3); 
1
H NMR (600 MHz, 
CDCl3): δ = 5.67 (dd, J = 10.4, 10.3 Hz, 1H), 5.52 (dd, J = 10.7, 1.7 Hz, 1H), 5.41 (td, J 
= 7.1, 1.6 Hz, 1H), 5.39 – 5.34 (m, 1H), 5.06 (d, J = 9.8 Hz, 1H), 4.73 (d, J = 6.8 Hz, 
1H), 3.02 – 2.89 (m, 1H), 4.62 (d, J = 6.8 Hz, 1H), 4.36 (dd, J = 9.6, 1.3 Hz, 1H), 3.87 
(ddd, J = 10.3, 7.4, 3.1 Hz, 1H), 3.44 (br s, 1H), 3.39 (s, 3H), 3.16 (ddq, J = 9.9, 9.7, 6.9 
Hz, 1H), 2.96 (br s, 1H), 2.82 (d, J = 16.2 Hz, 1H), 2.47 – 2.35 (m, 2H), 2.35 – 2.24 (m, 
2H), 2.20 (dt, J = 12.8, 7.7 Hz, 1H), 2.10 (ddq, J = 8.5, 7.1, 1.4 Hz, 1H), 2.05 – 1.94 (m, 
2H), 1.88 – 1.76 (m, 2H), 1.61 (d, J = 1.3 Hz, 3H), 1.66 – 1.33 (m, 4H), 1.46 (s, 3H), 
1.27 – 1.17 (m, 1H), 1.08 (d, J = 7.1 Hz, 3H), 0.99 (t, J = 7.0 Hz, 3H), 1.02 – 0.95 (m, 
3H), 0.94 (d, J = 6.8 Hz, 3H), 0.89 (s, 9H), 0.80 (d, J = 6.8 Hz, 3H), 0.11 (s, 12H), 0.07 
(s, 3H); 
13
C NMR (150 MHz, CDCl3): δ = 172.3, 170.4, 145.7, 137.1, 132.4, 130.9, 
127.1, 109.7, 99.1, 96.5, 87.5, 84.2, 83.3, 82.5, 75.0, 64.1, 56.2, 46.2, 44.0, 43.3, 42.1, 
37.6, 34.9, 34.3, 27.9, 27.2, 25.9, 25.9, 25.9, 22.8, 22.7, 18.4, 17.6, 16.9, 16.9, 12.1, 11.5, 
11.3, 9.2, 2.6, 2.6, 2.6, ‒4.3, ‒5.0; IR (film):  = 2956, 2929, 2861, 1729, 1462, 1375, 
1375, 1361, 1324, 1250, 1144, 1056, 1056, 1033, 1004, 985, 915, 836, 775, 752 cm
-1
; 
HRMS (ESIpos): m/z: calcd. for C44H76O8Si2Na [M
+
+Na]: 811.49710, found 811.49652. 
When applied to 43.5 mg (67.5 µmol) of vinyl iodide 3 this reaction yielded 10.0 mg 
(19%) of disilyl ether D1. 
Propargylic alcohol D2. TBAF (1 M in THF, 25.4 µL, 25.4 µmol) was slowly added to a 
suspension of disilyl ether D1 (10.0 mg, 
12.7 µmol) and activated 4Å molecular 
sieves (20.0 mg, powder) in THF 
(200 µL) at 0 °C. After 1.5 h, a second 
aliquot of TBAF (1 M in THF, 25.4 µL, 
25.4 µmol) was introduced. After additional 1.5 h, the reaction was quenched with 
H2O/brine (2:1, 5 mL) and diluted with EtOAc (5 mL). The aqueous layer was extracted 
with EtOAc (3 x 5 mL) and the combined organic layers were dried over Na2SO4 and 
concentrated in vacuo. The residue was quickly purified by flash chromatography 
(Florisil
®
, hexanes/EtOAc, 7:3  3:7), keeping the contact time with the stationary phase 
as short as possible. The yellow viscous liquid thus obtained presented a mixture (~1:1) 
of the title compound and the dehydrated lactone E2. It was immediately used in the next 
step as it decomposes upon storage in the freezer. HRMS (ESIpos): m/z: calcd. for 
C35H54O8Na [M
+
+Na]: 625.37109, found 625.37132. 
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Allylic alcohol D3. A solution of a mixture (~1:1) of propargyl alcohol D2 and 
dehydrated lactone E2 (5.0 mg, 8.3 µmol) 
in THF (300 µL) was added to a 
suspension of freshly prepared 
Zn(Cu/Ag) (570 mg) in degassed 
MeOH/H2O (1:1, 600 µL) and the 
resulting mixture was stirred at 50 °C for 89 h. After cooling to room temperature, the 
mixture was diluted with EtOAc (2 mL) and filtered through a short pad of Celite
®
, 
which was carefully rinsed with EtOAc (50 mL) and EtOH (5 mL). The combined 
filtrates were concentrated in vacuo. The residue was purified by flash chromatography 
(Florisil
®
, hexanes/EtOAc, 4:1  1:1) to yield the title compound as a colorless viscous 
liquid (1.9 mg, 23% yield over two steps, ~80% purity) along with the dehydrated lactone 
E3 as colorless viscous liquid (3.9 mg, 33% yield over two steps, ~55% purity). 
1
H NMR 
(600 MHz, CD2Cl2): δ = 6.44 (dd, J = 11.5, 11.4 Hz, 1H), 6.28 (dd, J = 11.3, 11.2 Hz, 
1H), 5.56 (dd, J = 11.4, 10.6 Hz, 1H), 5.51 – 5.43 (m, 1H), 5.28 (dd, J = 11.2, 10.8 Hz, 
1H), 5.15 – 5.10 (m, 1H), 5.05 (d, J = 10.3 Hz, 1H), 5.08 – 5.01 (m, 1H), 4.73 (d, J = 6.4 
Hz, 1H), 4.64 (d, J = 6.4 Hz, 1H), 3.89 – 3.86 (m, 1H), 3.41 (s, 3H), 3.35 (d, J = 10.7 Hz, 
1H), 2.99 – 2.92 (m, 1H), 2.86 (br s, 1H), 2.74 (d, J = 16.4 Hz, 1H), 2.62 – 2.54 (m, 1H), 
2.36 – 2.30 (m, 2H), 2.28 – 2.19 (m, 2H), 2.09 – 2.05 (m, 2H), 2.05 – 1.97 (m, 1H), 1.96 
– 1.89 (m, 1H), 1.88 – 1.77 (m, 2H), 1.65 (s, 3H), 1.62 – 1.58 (m, 2H), 1.50 – 1.46 (m, 
2H), 1.44 (s, 3H), 1.41 – 1.34 (m, 2H), 1.10 (d, J = 6.8 Hz, 3H), 1.07 (d, J = 7.3 Hz, 3H), 
1.01 (t, J = 7.4 Hz, 3H), 0.97 (d, J = 6.9 Hz, 3H), 0.86 (d, J = 6.7 Hz, 3H); HRMS 
(ESIpos): m/z: calcd. for C35H56O8Na [M
+
+Na]: 627.38674, found 627.38634. 
Allylic carbamate D4. A solution of trichloroacetyl isocyanate (0.1 M in CH2Cl2, 
20.0 µL, 2.00 µmol) was carefully added 
along the cold wall of a solution of the 
allylic alcohol D3 (1.5 mg, 2.48 µmol) in 
CH2Cl2 (100 µL) precooled at ‒78 °C. 
The reaction mixture was allowed to 
reach ‒78 °C and was stirred at this 
temperature for 30 min, when a second aliquot of trichloroacetyl isocyanate (0.1 M in 
CH2Cl2, 5.0 µL, 5.00 µmol) was introduced. After additional 15 min, a third aliquot of 
trichloroacetyl isocyanate (0.1 M in CH2Cl2, 3.0 µL, 3.00 µmol) was introduced and the 
mixture was stirred at ‒78 °C for 15 min, before being quenched with MeOH (50 µL) at 
this temperature. After warming and concentration in vacuo, the residue was dissolved in 
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CH2Cl2 (1 mL) and the solution soaked on basic alumina. After 1 h, the alumina was 
loaded onto a short pad of Celite
®
, which was eluted with EtOAc/EtOH (9:1, 50 mL) and 
the solvent was concentrated in vacuo. The residue was purified by preparative thin layer 
chromatography (TLC Silica gel 60 F254 (20 x 20 cm), hexanes/EtOAc, 7:3) to yield the 
title compound as a colorless viscous liquid (1.1 mg, 44%, ~80% purity). 
1
H NMR (500 
MHz, CD2Cl2): δ = 6.73 – 6.60 (m, 1H), 6.42 – 6.23 (m, 1H), 6.01 – 5.81 (m, 1H), 5.56 – 
5.42 (m, 2H), 5.37 – 5.33 (m, 1H), 5.12 – 5.06 (m, 1H), 5.04 (d, J = 10.3 Hz, 1H), 4.70 
(d, J = 6.7 Hz, 1H), 4.59 (d, J = 6.7 Hz, 1H), 4.49 (br s, 2H), 3.87 (ddd, J = 9.9, 7.6, 3.1 
Hz, 1H), 3.38 (s, 3H), 3.35 – 3.27 (m, 1H), 3.00 – 2.91 (m, 1H), 2.73 (d, J = 16.5 Hz, 
1H), 2.53 – 2.45 (m, 1H), 2.34 (d, J = 16.5 Hz, 1H), 2.30 – 2.25 (m, 1H), 2.24 – 2.11 (m, 
3H), 2.08 (q, J = 7.2 Hz, 2H), 2.02 (d, J = 6.4 Hz, 1H), 1.88 – 1.75 (m, 2H), 1.67 – 1.64 
(m, 3H), 1.63 – 1.58 (m, 2H), 1.50 – 1.45 (m, 2H), 1.41 – 1.35 (m, 2H), 1.26 (s, 3H), 1.13 
(d, J = 7.3 Hz, 3H), 1.09 (d, J = 6.7 Hz, 3H), 1.01 (t, J = 7.4 Hz, 3H), 0.97 (d, J = 6.9 
Hz, 3H), 0.86 (d, J = 6.6 Hz, 3H); HRMS (ESIpos): m/z: calcd. for C36H57NO9Na 
[M
+
+Na]: 670.39255, found 670.39212. 
Analogue 42. A solution of allylic carbamate B4 (0.8 mg, 1.23 µmol) in CH2Cl2 (120 
µL) was cooled to ‒90 °C (Et2O/CO2/N2 
cooling bath) before a solution of freshly 
prepared Me2BBr (0.1 M in CH2Cl2, 14.9 µL, 
1.49 µmol) was carefully added via the cold 
wall of the flask. The reaction mixture was 
allowed to reach ‒78 °C and was stirred at 
this temperature for 1 h, when a second aliquot of Me2BBr (0.1 M in CH2Cl2, 14.9 µL, 
1.49 µmol) was introduced. After additional 0.5 h, the mixture was transferred via canula 
into a vigorously stirred mixture of sat. NaHCO3/H2O/THF (1:1:1, 3 mL) and the flask 
was rinsed with THF (2 x 200 µL). After stirring for 0.5 h, the mixture was diluted with 
EtOAc (3 mL), the aqueous layer was extracted with EtOAc (3 x 3 mL), the combined 
organic layers were dried over Na2SO4 and concentrated in vacuo. The residue was 
purified by preparative thin layer chromatography (TLC Silica gel 60 F254 (20 x 20 cm), 
MeOH/CH2Cl2, 7:93) to yield the title compound as a colorless viscous liquid (0.56 mg, 
63%, ~90% purity). 
1
H NMR (500 MHz, CD2Cl2): δ = 6.52 (dd, J = 11.5 , 11.4 Hz, 1H), 
6.37 (dd, J = 11.3, 11.2 Hz, 1H), 5.90 (d, J = 10.1 Hz, 1H), 5.57 – 5.45 (m, 3H), 5.13 – 
5.06 (m, 1H), 5.03 (d, J = 10.3 Hz, 1H), 4.64 (br s, 2H), 3.87 (ddd, J = 10.3, 7.6, 3.2 Hz, 
1H), 3.26 (br t, J = 9.7 Hz, 1H), 3.00 – 2.90 (m, 1H), 2.74 (d, J = 16.5 Hz, 1H), 2.45 (dq, 
J = 10.5, 6.6 Hz, 1H), 2.34 (d, J = 16.5 Hz, 1H), 2.32 – 2.26 (m, 1H), 2.24 – 2.16 (m, 
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2H), 2.17 – 2.11 (m, 1H), 2.11 – 2.03 (m, 2H), 2.03 – 1.95 (m, 1H), 1.88 – 1.78 (m, 2H), 
1.77 – 1.70 (m, 1H), 1.65 (d, J = 1.3 Hz, 3H), 1.64 – 1.55 (m, 2H), 1.49 – 1.43 (m, 2H), 
1.42 (d, J = 1.4 Hz, 3H), 1.40 – 1.33 (m, 2H), 1.13 (d, J = 6.7 Hz, 3H), 1.08 (d, J = 7.3 
Hz, 3H), 1.01 (t, J = 7.4 Hz, 3H), 0.97 (d, J = 6.9 Hz, 3H), 0.86 (d, J = 6.6 Hz, 3H); 
HRMS (ESIpos): m/z: calcd. for C34H53NO8Na [M
+
+Na]: 626.36634, found 626.36684. 
 
 Analogue F  
Allylic acetate F4. Acetic anhydride (2.3 µL, 25 µmol), triethylamine (4.6 µL, 33 µmol) 
and DMAP (0.2 mg, 1.7 µmol) were 
added subsequently to a ‒78°C solution 
of alcohol 40 (10.0 mg, 16.6 µmol) in 
CH2Cl2 and stirred for 1 h. The reaction 
mixture was then allowed to warm to 
0 °C and stirred for further 18 h before 
being quenched with a mixture of brine and H2O (1:1, 4 mL). The aqueous layer was 
extracted with CH2Cl2 (3 x 4 mL) and the combined organic layers were dried over 
Na2SO4 and concentrated in vacuo. The residue was purified by flash column 
chromatography (silica, hexanes/EtOAc, 3:1  2:1) to yield the desired mono-acetylated 
F4 product as a white solid (5.8 mg, 54% yield, ~95% purity) along with the bis-
acetylated compound as an off-white foam (3.1 mg, 27% yield). D20][ = ‒65.7 (c = 0.48, 
CH2Cl2). 
1
H NMR (600 MHz, CD2Cl2): δ = 6.65 (br t, J = 12.2 Hz, 1H), 6.38 (ddt, J = 
15.0, 10.7, 1.2 Hz, 1H), 6.31 (br t, J = 10.3 Hz, 1H), 6.09 (dd, J = 10.8, 1.7 Hz, 1H), 6.03 
(d, J = 10.8 Hz, 1H), 5.75 (dt, J = 15.2, 7.6 Hz, 1H), 5.47 (br t, J = 10.0 Hz, 1H), 5.36 – 
5.30 (m, 1H), 5.09 – 5.04 (m, 2H), 4.66 (d, J = 6.7 Hz, 1H), 4.55 (d, J = 6.7 Hz, 1H), 
3.90 (ddd, J = 10.3, 7.5, 3.2 Hz, 1H), 3.36 (s, 3H), 3.27 (br s, 1H), 2.97 (ddq, J = 10.3, 
6.7, 6.6 Hz, 1H), 2.72 (d, J = 16.5 Hz, 1H), 2.52 – 2.44 (m, 1H), 2.41 (dd, J = 14.0, 
7.4 Hz, 1H), 2.34 (d, J = 16.5, 0.9 Hz, 1H), 2.32 – 2.27 (m, 1H), 2.24 – 2.17 (m, 4H), 
2.00 – 1.95 (m, 2H), 1.94 (s, 3H), 1.88 (dq, J = 9.8, 7.1 Hz, 1H), 1.84 (ddd, J = 14.7, 7.3, 
3.2 Hz, 1H), 1.78 (d, J = 1.0 Hz, 3H), 1.77 – 1.74 (m, 1H), 1.68 – 1.54 (m, 3H), 1.15 (d, 
J = 7.4 Hz, 3H), 1.07 (d, J = 6.8 Hz, 3H), 1.02 – 0.99 (m, 6H), 0.86 (d, J = 6.6 Hz, 3H). 
13
C NMR (150 MHz, CD2Cl2): δ = 172.5, 170.4, 170.3, 137.6, 137.2, 135.6, 134.3, 131.9, 
129.9, 129.2, 128.5, 126.4, 125.0, 99.1, 86.1, 84.1, 83.0, 72.4, 66.8, 56.5, 48.4, 43.4, 43.1, 
42.3, 34.0, 27.4, 22.6, 21.6, 16.9, 16.7, 13.8, 12.3, 11.8, 11.6, 9.4; IR (film):  = 3480, 
2967, 2930, 1732, 1457, 1369, 1243, 1208, 1148, 1091, 1036, 949, 748 cm
-1
; MS (ESI) 
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m/z (%): 667.5 (100); HRMS (ESIpos): m/z: calcd. for C37H56O9Na [M
+
+Na]: 
667.38165, found 667.38167. 
Analogue 45. A solution of allylic acetate F4 (4.8 mg, 7.4 µmol) in CH2Cl2 (0.8 mL) was 
cooled to ‒90 °C (Et2O/CO2/N2 cooling bath) 
before a solution of freshly prepared Me2BBr 
(0.5 M in CH2Cl2, 16.4 µL, 8.2 µmol) was 
carefully added via the cold wall of the flask. 
The mixture was allowed to reach ‒78 °C 
and was stirred at this temperature for 1.5 h, 
when a second aliquot of Me2BBr (0.5 M, 16.4 µL, 8.2 µmol) was introduced. The 
reaction mixture was stirred for 1.5 h, when a third aliquot of Me2BBr (0.5 M, 16.4 µL, 
8.2 µmol) was introduced. After additional 1.5 h, the mixture was transferred via canula 
into a vigorously stirred mixture of sat. NaHCO3/H2O/THF (1:1:1, 7 mL) and the flask 
was rinsed with THF (2 x 0.5 mL). After stirring for 10 min, the mixture was diluted with 
EtOAc (10 mL), the aqueous layer was extracted with EtOAc (3 x 10 mL), the combined 
organic layers were dried over Na2SO4 and concentrated in vacuo. The residue was 
purified by preparative thin layer chromatography (TLC Silica gel 60 F254 (20 x 20 cm), 
hexanes/EtOAc, 1:1) to yield the title compound as an off-white solid (2.4 mg, 54% 
yield). 
1
H NMR (600 MHz, CD2Cl2): see Table S-5; 
13
C NMR (150 MHz, CD2Cl2): see 
Table S-5; IR (film):   = 3472, 2956, 2924, 2854, 1733, 1459, 1371, 1259, 1246, 1207, 
1149, 1100, 1015, 979 cm
-1
MS (ESI) m/z (%): 593.4 (100); HRMS (ESIpos): m/z: calcd. 
for C34H50O7Na [M
+







C data of leiodermatolide 




H (CD2Cl2, 600 MHz) 
13
C NMR (CD2Cl2, 150 MHz) 
Nr  (ppm) Integral Splitting COSY J (Hz)  (ppm) HMBC 
1 – – – – – 172.4 2ab, 3, 15 
2a 2.31 1 ddd 2b, 3 16.7, 6.2, 2.8 
34.0 3, 4, (26) 
2b 1.99 1 ddd 2a, 3 16.7, 11.0, 3.2 
3 2.25 – 2.18 2 m 2ab, 4 – 22.5 2a(b), 4 
4 5.11 1 ddd 3ab, 26 9.4, 5.1, 1.2 126.1 2ab, 3, 6, 26 
5 – – – – – 137.4 3, 6, 26, 27 
6 2.44 1 dq 7, 27 9.0, 6.6 48.5 4, (8), 26, 27 
7 3.31 1 br d 6, OH 8.7 78.6 6, (8), 9, 27, 28 
8 1.77 1 q 28 7.3 39.4 (9), (10), 28 
9 6.02 1 d 10 10.3 67.0 (8), 11, 28, 35 
10 5.52 1 ddt 9, 11, 13 10.6, 10.3, 1.2 128.6 (8), 9, 12 
11 6.36 1 dd 10, 13 11.6, 10.8 126.3 9, 12, 13 
12 6.56 1 dd 11, 13 11.5, 11.3 124.8 10, 11, 14 
13 5.35 1 ddt 10, 12, 14 11.2, 10.1, 1.2, 137.8 11, (13), 14, 15, 29 
14 2.98 1 ddq 13, 15, 29 10.1, 7.9, 6.6 35.3 12, 13, 15, 29 
15 5.08 1 d 14 10.3 82.8 (12), 14, 17, 29, 30 
16 – – – – – 134.2 14, 15, (17), 18, 30 
17 6.10 1 dq 18, 30 10.8, 1.1 129.9 15, 18, 19, 30 
18 6.40 1 ddt 17, 19, 20 14.9, 10.6, 0.8 131.9 17, 20ab, 30 
19 5.76 1 ddd 18, 20ab 15.0, 7.6, 7.5 128.4 17, 20ab, (30) 
20a 2.24 – 2.19 1 m 19, 20b – 
38.9 18, 19, 22, 32ab 
20b 2.41 1 dd 19, 20a 13.6, 7.4 
21 – – – – – 72.4 19, 20ab, 22, 32ab, 31 
22 1.89 1 dq 23, 31 10.0, 6.8 43.4 (23), 24ab, 31, 32ab 
23 3.91 1 ddd 22, 24a, 24b 10.1, 7.3, 3.0 84.1 22, 24ab, 25, 31 
24a 1.85 1 dqd 23, 24b, 25 14.7, 7.3, 3.2 
27.4 22, (23), 25, 31 
24b 1.63 1 dqd 23, 24a, 25 14.6, 7.4, 7.3 
25 1.02 3 t 24ab 7.4 9.42 23, 24ab, (31) 
26 1.43 3 s 4 – 11.6 4, 6 
27 1.11 3 d 6 6.7 16.6 6 
28 1.10 3 d 8 7.3 12.9 8, 9 
29 0.87 3 d 14 6.7 16.9 13, 14, 15 
30 1.80 3 d 17 1.2 12.3 15, 17 
31 1.02 3 d 22 6.5 11.9 22, (23) 
32a 2.73 1 d 32b 16.4 
43.1 20ab, 22 
32b 2.35 1 dd 32a 16.4, 1.0 
33 – – – – – 170.3 32ab 
34 – – – – – 171.5 9, 35 
35 1.98 3 s – – 21.7 – 
C7-OH 1.66 – 1.63 1 – 7  – – 




Analogue 46. A solution of alcohol 40 (4.0 mg, 6.66 µmol) in CH2Cl2 (0.71 mL) was 
cooled to -90 °C (Et2O/CO2/N2 cooling bath) 
before a solution of freshly prepared Me2BBr 
(0.5 M in CH2Cl2, 30.6 µL, 15.3 µmol) was 
carefully added via the cold wall of the flask. 
The mixture was allowed to reach -78 °C and 
was stirred at this temperature for 1.5 h, when a second aliquot of Me2BBr (0.5 M, 
14.6 µL, 15.3 µmol) was introduced. This was repeated after another 1.5 h. After 
additional 1.5 h, the mixture was transferred via canula into a vigorously stirred mixture 
of sat. NaHCO3/H2O/THF (1:1:1, 7 mL) and the flask was rinsed with THF (2 x 0.5 mL). 
After stirring for 10 min, the mixture was diluted with EtOAc (10 mL), the aqueous layer 
was extracted with EtOAc (3 x 10 mL), the combined extracts were dried over Na2SO4 
and concentrated. The residue was purified by preparative thin layer chromatography 
(TLC Silica gel 60 F254 (20 x 20 cm), hexanes/EtOAc, 3:2) to give the title compound as 
an off-white solid (1.1 mg, ~75% purity, 20% yield). 
1
H NMR (600 MHz, CD2Cl2): δ = 
see Table S-6; 
13
C NMR (150 MHz, CD2Cl2): δ = see Table S-6; IR (film):  = 3469, 





MS (ESI) m/z (%): 593.4 (100); HRMS (ESIpos): m/z: calcd. for C34H50O7Na 
[M
+








C data of dioxane 46; 




H NMR (CD2Cl2, 600 MHz) 
13
C NMR (CD2Cl2, 150 MHz) 
Nr  (ppm) Integral Splitting COSY J (Hz)  (ppm) HMBC 
1 - - - - - 172.4 2, 15 
2a 2.31 - 2.38 1H m 2b, 3a, 3b - 
33.8 1, 3, 5, 26 
2b 1.88 - 1.96 1H m 2a, 3a, 3b - 
3 2.18 - 2.30 2H m 2a, 2b, 4 - 22.1 1, 2, 4, 26 
4 5.12 1H dd 3a, 3b, (26) 10.2, 4.5 126.1 2, 3, 6, 26 
5 - - - - - 137.0 3, 6, 7, 26, 27 
6 2.49 1H dq 7, 27 10.9, 6.6 48.3 4, 5, 7, 26, 27 
7 3.44 1H d 6 11.0 80.4 6, 9, 27, 28, 29 
8 1.60-1.66 1H m 7, 9, 29 - 38.4 7, 9, 10, 29 
9 5.07 1H d 10 10.1 65.2 7, 8, 11, OH1, 29 
10 5.56 – 5.60 1H m 9, 11 -- 131.7 8, 9, 12, OH1 
11 6.31 – 6.38 1H m 10, 12 -- 123.7 9, 12, 13, 14 
12 6.46 1H dd 11, 13 10.3, 11.4 126.7 10, 13, 14, 30 
13 5.28 1H dd 12, 14 10.3, 10.2, 0.7 137.7 11, 14, 15, 30 
14 2.96 - 3.02 1H m 13, 15, 31 - 35.3 12, 13, 15, 30 
15 5.09 1H d 14 10.3 83.1 13, 14, 16, 17, 30, 31 
16 - - - - - 134.0 14, 15, 17, 18 
17 6.05 1H d 18 10.8 129.7 15, 16, 18, 19, 31 
18 6.38 – 6.42 1H m 17, 19 - 131.7 17, 20, 31 
19 5.77 1H ddd 20a, 20b 7.5, 7.5, 15.1 128.3 17, 18, 20, 21 
20a 2.41 1H dd 19, 20b 14.3, 7.9 
38.7 18, 19, 21, 22, 33 
20b 2.22 1H dd 19, 20a 14.2, 7.6 
21 - - - - - 72.1 19, 20a, 20b, 22, 33 
22 1.89 1H dq 23, 32 10.1, 7.1 43.2 20, 32, 33 
23 3.91 1H ddd 22, 24a, 24b 10.1, 7.4, 2.9 83.9 22, 24, 25 
24a 1.86 – 1.90 1H m 23, 24b, 25 - 
27.2 23, 25 
24b 1.63 1H ddq 23, 24b, 25 7.3, 7.3, 7.4 
25 1.02 3H t 24a, 24b 7.2 9.2 24 
26 1.44 3H s 4 - 11.3 4, 5, 6 
27 1.11 3H d 6 6.9 16.1 5, 7 
28a 5.00 1H d 28b 6.2 
88.7 7,9 
28b 4.80 1H d 28a 6.3 
29 1.07 3H d 8 7.2 12.1 6, 9, (28) 
30 0.87 3H d 14 6.8 16.6 13, 14, 15 
31 1.79 3H d 17 0.6 12.2 15, 17 
32 0.98 3H d 22 6.9 11.7 21, 22 
33a 2.73 1H d 33b 16.5 
42.9 21, 34 
33b 2.35 1H d 33a 16.6 
34 - - - - - 170.1 33a, 33b 
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Comparison of the 
1
H NMR (600 MHz) of Leiodermatolide (1) and MOM-protected precursor 41; signals that resolve after deprotection are marked in red.  
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